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ABSTRACT 
The fundamental building blocks for constructing complex synthetic gene networks are 
effective biological parts with wide dynamic range, low crosstalk, and modularity. RNA-based 
components are promising sources of such parts since they can provide regulation at the level of 
transcription and translation and their predictable base pairing properties enable large libraries to 
be generated through in silico design. This dissertation studies two different approaches for 
initiating interactions between RNA molecules to implement RNA-based components that achieve 
translational regulation. First, single-stranded domains known as toeholds were employed for 
detection of the highly prevalent foodborne pathogen norovirus. Toehold switch riboregulators 
activated by trigger RNAs from the norovirus RNA genome are designed, validated, and coupled 
with paper-based cell-free transcription-translation systems. Integration of paper-based reactions 
with synbody enrichment and isothermal RNA amplification enables as few as 160 copies/mL of 
norovirus from clinical samples to be detected in reactions that do not require sophisticated 
equipment and can be read directly by eye. Second, a new type of riboregulator that initiates 
RNA-RNA interactions through the loop portions of RNA stem-loop structures was developed. 
These loop-initiated RNA activators (LIRAs) provide multiple advantages compared to toehold-
based riboregulators, exhibiting ultralow signal leakage in vivo, lacking any trigger RNA sequence 
constraints, and appending no additional residues to the output protein. Harnessing LIRAs as 
modular parts, logic gates that exploit loop-mediated control of mRNA folding state to implement 
AND and OR operations with up to three sequence-independent input RNAs were constructed. 
LIRA circuits can also be ported to paper-based cell-free reactions to implement portable systems 
with molecular computing and sensing capabilities. LIRAs can detect RNAs from a variety of 
different pathogens, such as HIV, Zika, dengue, yellow fever, and norovirus, and after coupling to 
isothermal amplification reactions, provide visible test results down to concentrations of 20 aM 
(12 RNA copies/µL). And the logic functionality of LIRA circuits can be used to specifically identify 
different HIV strains and influenza A subtypes. These findings demonstrate that toehold- and 
loop-mediated RNA-RNA interactions are both powerful strategies for implementing RNA-based 
computing systems for intracellular and diagnostic applications.  
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CHAPTER 1 
INTRODUCTION 
1.1 Synthetic biology 
 Synthetic biology is a highly interdisciplinary research field that integrates our current 
understanding of several subjects, such as biology, chemistry and engineering. Biology studies 
provide us with deeper understanding of natural systems, from which we can learn the basic 
mechanisms that hide behind biological interactions and develop new ideas to engineer natural 
systems by integrating them with engineering approaches. Novel molecules and molecular 
systems that are required for carrying out modifications in synthetic biology can be synthesized 
by chemistry1. The term ‘synthetic biology’ was first used by Barbara Hobom in 1980 for bacteria 
that had been engineered via recombinant DNA technology2,3. Indeed, the development of 
genetic engineering technologies paved the way for the development of synthetic biology. The 
advent of genetic engineering dates back to the 1960s, when the study of lac operon in E. coli 
demonstrated the regulatory circuits exist in natural systems4. Later in the 1970s and 1980s, 
genetic manipulation techniques, such as molecular cloning and PCR techniques, gradually 
became more and more widely used in molecular biology research5. During the 1990s, 
automated DNA sequencing and high-throughput analysis of RNA, protein and other cellular 
components were developed. These large data-based studies drove researchers to analyze 
organisms in an entirely way and study biological networks in a ‘top-down’ way. Those studies 
were then classified as a new discipline, termed ‘systems biology’6-8. From systems biology, 
researchers gradually made it clear that how different biological parts function in natural systems, 
and what influence would they bring to natural systems by making modifications to those 
biological parts. With the development of our understanding of versatile biological parts, a 
‘bottom-up’ approach for biological network construction was gradually developed, in which well-
defined biological parts attained from systems biology studies were constructed into complex 
biological circuits to fulfill artificial functions. This discipline was then termed as ‘synthetic biology’. 
 The goal of synthetic biology is to endow organisms with the ability to carry out new 
biological functions. Synthetic biologists tend to take computer hardware engineering as an 
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example, in which transistors, capacitors and resistors work as the bottom layer, which could be 
assembled into gates, modules and finally into computers. Computers in different locations can 
contact each other by networks. Similarly, in synthetic biology, starting from basic biological 
materials, such as DNA, RNA and protein, devices with a single or multiple predefined functions 
are first designed. Multiple devices that could implement different functions work together to 
generate versatile biological circuits, which then bring new biological functions to host cells. To 
carry out more sophisticated tasks that cannot be done by a single cell population, multiple cell 
populations can be engineered to communicate and coordinate with each other. In such systems, 
different cell populations need to be endowed with different functions that are required in the 
targeting coordinate tasks. Those cell populations can be ‘wired’ together with predefined 
biological circuits, using small molecules or proteins as signals for transmission8. Thus, no matter 
in single-cell or cell-population engineering, biological circuits with reliable synthetic function 
represents fundamental building blocks in synthetic biology. 
For constructing artificial biological circuits, synthetic biologists adopt two different 
approaches. One is by using unnatural molecules to reproduce biological behavior, and the other 
one is by assembling biological parts into artificial biological circuits2. However, unlike electric 
circuits, in which different devices and modules are well insulated, all biological components are 
randomly distributed in cells and affected by cellular environment. Considering our incomplete 
understanding of biological systems, the assembly of parts into complex synthetic circuits is still 
hindered by unknown interactions in cellular environment. Moreover, the complexity of part 
coordination will increase exponentially with the increasing number of parts being incorporated 
into circuits9. Last but not least, engineered biological devices and circuits that function well in 
one type of cellular context may not work well or may even be toxic when transferred into other 
types of cells or organisms9. 
 Although a lot of obstacles obstruct the ability to engineer versatile biological devices and 
circuits, researchers have developed numerous biological devices and circuits with complex 
functions in the past two decades. In DNA level designs, genetic circuits were successfully 
constructed, including genetic toggle switch10, synthetic oscillator11-14, recombinase genetic 
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switch15 and derived logic gates16-18, counters19, promoter regulation based logic circuits20-24, 
orthogonal ribosome based logic circuits25, noise propagation cascade26, band-pass filter27, E. coli 
based optical sensors28,29 and time-delay circuits30, etc. For RNA-level constructs, lots of designs 
were also successfully tested, like ligand-responsive riboregulator31 and derived logic gates32, 
RNAi based genetic switch33 and derived logic circuits34, riboswitches35-45, ligand-responsive 
ribozyme46, engineered riboregulator47, engineered ribosome-mRNA pairs48, small transcription 
activating RNAs49 and transcriptional activators50,51, etc. With respect to protein-level, biological 
circuits with high efficiency were also constructed, although not as many as DNA or RNA based 
designs, such as protein based allosteric gating52, protein receptors for non-native target ligands53, 
protein-binding domain based logic gates54, transcription effector based logic gates55 and 
proteolysis-based logic circuits56, etc. Even for synthetic pathway construction and multicellular 
communication, researchers also obtained great breakthroughs, such as the constructions of 
butanol producing pathway57, artemisinic acid producing pathway58 and fuels and chemicals 
producing pathways59-61, as well as multicellular systems, like pulse generator62, programmed 
pattern formation63, programmed population control64, analog-to-digital converter65, 
programmable full-adder66, etc. 
 The above circuit classifications are not quite stringent, since every circuit requires 
incorporation of all cellular components, including DNA, RNA, proteins, etc., from host cells to 
carry out their functions. The rough classification only considered the engineered part that plays a 
more important role in their designed biological functions. But from the biological circuits listed 
above, we can clearly see that the studies of DNA and RNA based circuits have advanced more 
than protein, pathway and multicellular studies. This is likely the result of the ease of engineering 
DNA and RNA compared with relatively higher difficulty for protein, pathway and multicellular 
engineering, considering our limited understanding of biological mechanisms. DNA or RNA based 
researches have more clues for people to follow. Versatile molecular biological techniques have 
been developed for researchers to modify or to engineer DNA and RNA outside or inside the cells. 
Unlike protein, which consists of 20 amino acids and unpredictable structures, DNA and RNA 
only contains four bases with predictable Watson-Crick base pairing rules, whose structure is 
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more predictable. Using DNA and RNA sequencing techniques, DNA or RNA sequences that 
have biological functions can be well identified, which facilitate the modification and reconstitution 
of their biological functions. With the predictable base pairing rules and well defined biological 
functions, engineered DNA or RNA molecules with prescribed functions and predefined structures 
can be well designed, which lessens the burden of devices screening and tuning. For the 
enumerated DNA studies, most of them rely on protein controlled gene transcription in cells, 
either with transcription factors or repressors. 
 
1.2 General genetic circuits 
 In the year of 2000, the development of toggle switch design led to a breakthrough in 
synthetic biology studies. The toggle switch is a DNA sequence containing multiple domains with 
biological functions, which consists of two repressor genes regulated by two constitutive 
promoters10. Each repressor gene encodes for a repressor protein, which can inhibit the 
transcription of the other repressor gene by inhibiting the binding of RNA polymerase with its 
corresponding constitutive promoter (Fig. 1.1A). The mutual inhibition of those two repressors 
leads to bi-stable behavior that is without inducer, either repressor 1 or repressor 2 induced by 
promoter 1 or promoter 2 can be expressed predominantly in the cells transformed with an 
engineered plasmid containing the toggle switch DNA construct. The current active promoter can 
be switched to the opposite promoter by adding the inducer to deactivate current active repressor 
proteins, which permits the expression of opposite repressor proteins to inhibit current active 
promoter. 
 In the actual design, two pairs of promoter and repressor were selected. One pair is Ptrc-
2 promoter (promoter 2) and Lac repressor (lacI, repressor 2), which can be inhibited by inducer 
IPTG, and the other pair is PLs1con promoter (promoter 1) and a temperature-sensitive λ 
repressor (cIts, repressor 1), which can be inhibited by elevating temperature (Fig. 1.1A). 
Reporter protein is GFP, which is also regulated by promoter 2. In principle, with the addition of 
IPTG, expression of genes regulated by promoter 2, including repressor 1 and GFP genes, can 
be induced, so the fluorescence signal can be detected at this stage (Fig. 1.1B). The expression 
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of repressor 1 protein will block the binding of RNA polymerase and promoter 1, so expression of 
repressor 2 can also be inhibited. When IPTG was removed from the culture medium, since no 
repressor 2 protein is synthesized by the host cell, promoter 2 will remain active, which keeps 
inducing the expression of GFP and repressor 1 proteins. However, when temperature increases, 
repressor 1 proteins will be deactivated and cannot inhibit the function of promoter 1, thus 
repressor 2 protein regulated by promoter 1 can start to express to inhibit promoter 2, which 
terminates the expression of repressor 1 and GFP reporter proteins. In this case, a decreasing 
fluorescence signal should be detected. 
 Oscillator systems are another example of using promoter-repressor pairs11. In this 
design, three promoter-repressor pairs were constructed into one plasmid, including PLlac 
promoter and lacI repressor, PLtet promoter and tetR repressor, λPR promoter and λcI repressor 
(Fig. 1.2A).  The first repressor protein, lacI blocks the binding between RNA polymerase and 
PLlac promoter, so the expression of lacI will inhibit the expression of the second repressor, tetR. 
And tetR inhibits the interaction of RNA polymerase with PLtet promoter, and thus regulate the 
expression of the third repressor cI, which is arranged to inhibit the expression of lacI repressor 
protein to complete the cycle by inhibiting λPR promoter. The reporter protein appears on a 
separate plasmid, whose expression is inhibited by tetR repressor. A transient pulse of IPTG will 
deactivate the function of lacI repressor protein, which can induce the expression of tetR 
repressor. The expression of tetR repressor will then inhibit the expression of both cI repressor 
and GFP protein. Thus, by adding IPTG, GFP signal strength will decrease initially. While the 
expression of cI repressor is repressed, λPR promoter will be activated, so the expression of lacI 
repressor will be turned on. Once the expressed lacI repressor compete the transiently inputted 
IPTG pulse, it will inhibit the binding of RNA polymerase with PLlac promoter again, and the 
expression of tetR repressor will then be repressed, and GFP expression can be turned on. This 
three pairs of promoter-repressor construction thus leads to an oscillatory expression of GFP 
protein, which is reflected in fluorescence strength output (Fig. 1.2B). 
 A counter was developed in a different way, which takes advantage of transcriptional 
cascade19. Two different riboregulated transcriptional counters (RTC) were developed, with one 
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can count to two, and the other one can count to three (Fig. 1.3). For the RTC two-counter, 
constitutive promoter PLtet0-1 drives the transcription of T7 RNA polymerase gene, which is 
encoding for T7 RNA polymerase. And transcription of GFP protein gene is carried out by T7 
RNA polymerase (Fig. 1.3A). However, the transcribed T7 RNA polymerase and GFP protein 
mRNAs are regulated by riboregulators, which will inhibit the translation process by blocking RBS 
(ribosome binding site) to interrupt the binding of ribosome with mRNAs. To turn on the 
translation of these riboregulated mRNAs, a trans-activating RNA (taRNA) is designed to contain 
sequence that is complementary to the riboregulators, so once taRNA is transcribed by adding 
inducer arabinose, the structure of riboregulator will be disrupted, and the expression of T7 RNA 
polymerase and GFP proteins will also be turned on. Before adding arabinose, repressed T7 
RNA polymerase mRNAs are automatically synthesized by host cells with the constitutive 
promoter. After the first pulse of arabinose, a short burst of taRNA can be transcribed, which will 
then disrupt the riboregulator of the repressed T7 RNA polymerase mRNA to turn on the T7 RNA 
polymerase expression. Then the arabinose was removed from the culture medium by centrifuge 
and wash, and remained intracellular arabinose and synthesized taRNA are gradually 
metabolized from host cells. In this case, T7 RNA polymerase that had been synthesized inside 
the cell can transcribe riboregulated GFP mRNA. Until the next arabinose pulse to induce the 
transcription of another burst of taRNA, GFP expression will remain at OFF state (Fig. 1.3B). A 
RTC three-counter was constructed in the same way, by inserting the T3 RNA polymerase 
synthesis in the middle (Fig. 1.3C&D). 
 Logic gate is another hot topic research field in synthetic biology, and most of the 
constructed logic gate circuits usually take advantage of interactions between protein, DNA and 
RNA. Layered designs are typically used for constructing complex circuits, in which outputs of 
one layer are designed into inputs for next layers. As shown in Figure 1.4, the two inputs of the 
whole logic circuit are two small molecules, and the outputs of the logic circuit are fluorescent 
proteins. Logic computation occurs in the processing unit, lies in the middle of the logic circuit. In 
the transcriptional control process, input molecules 1 and 2 can abolish transcription factors TF1 
and TF2 respectively, which can interact with their corresponding promoters to activate the 
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transcription of downstream DNAs into mRNAs. TF1 can activate the transcription of RNA-binding 
proteins, and TF2 can activate the transcription of a mRNA containing a regulatory part (BOX) 
and reporter protein gene. In the translational control level, the expressed RNA-binding protein 
binds with the regulatory part of the mRNA activated by TF2 to inhibit the translation of reporter 
proteins, so for overall circuit, it forms a N-IMPLY logic. To turn on the fluorescence output signal, 
molecule 1 is required to be added into the system to abolish TF1, so that the RNA-binding 
protein cannot be expressed. Molecule 2 is required not to be added, so the transcription of 
mRNA can be successfully processed by TF2 inducement. 
The regulation mechanisms for the above DNA based genetic circuits are usually 
designed at transcriptional level, with transcription factor and repressor proteins as major acting 
components. However, with the development of RNA biology, more and more natural RNA-based 
regulatory systems have been discovered in natural systems either in transcriptional and 
translational levels, which demonstrated an important role of RNA level regulations. 
 
1.3 RNA based regulation of gene expression 
 From its position at the center of central dogma, RNA plays an important role in 
regulation of gene expression in both prokaryotic and eukaryotic cells. Antisense RNAs67,68, small 
interfering RNA (siRNA)69-71 and MicroRNA (miRNA)72-74 can repress gene expression by binding 
with specifically targeting sequences in mRNAs. Riboregulator RNAs75,76 can cause 
conformational change of mRNAs to turn on or turn off gene expression by binding with targeting 
domains. Ribozymes77-79 located in mRNAs can affect gene expression by self-cleavage. 
Riboswitches, which can bind small molecules to regulate gene expression, are also discovered 
and have been well studied. 
 
1.3.1 Riboswitch 
 A riboswitch is a non-coding RNA located in the 5’ untranslated region of mRNAs, which 
can bind with small ligand molecules, such as nucleotides42,45, amino acids43 and other small 
molecules39,40,44. Binding with ligand molecule will cause conformational change of riboswitch 
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RNA, which then block or release RNA domains with biological functions to carry out downstream 
interactions. Riboswitch can either sequester or release RBS domain to regulate gene expression 
at translational level by binding with small molecules, or regulate gene expression at 
transcriptional level by disrupting the formation of transcriptional terminators. 
Thiamine pyrophosphate (TPP) binding riboswitch is a widely distributed riboswitch, 
which can regulate gene expression in both transcriptional and translational levels44. TPP is an 
active form of vitamin B1, which plays an important role in protein-catalyzed reactions. And as a 
metabolite-sensing RNA regulatory system, TPP-binding riboswitches are widely distributed in all 
species, which regulate the importation or synthesis of thiamine and its derivatives.  As shown in 
Figure 1.5A, with higher TPP concentration, the structure of riboswitch will stay in a condition, in 
which the Shine-Dalgarno (SD) sequence is sequestered in a hairpin structure. In this case, 
expression of downstream protein is repressed. When the concentration of TPP decreases below 
the threshold, a conformational change of riboswitch structure will occur, and the sequestered SD 
domain will also be released to a linear structure. In this condition, ribosome can recognize the 
SD domain to translate downstream gene into proteins. 
With respect to transcriptional level control, the conformational change of riboswitch can 
regulate the formation of transcriptional terminators. With TPP binding, riboswitch structure can 
be stably formed together with the transcriptional terminator (Fig. 1.5B), which can terminate 
transcription to generate truncated mRNAs. But when TPP is removed, the interaction between 
riboswitch and transcription terminator will disrupt both of their structures, so that full-length 
mRNA can be successfully transcribed, and gene expression is thus tuned on. 
Although riboswitches are widely distributed in nature, they are very sensitive to 
sequence changes, since their sequences are derived from natural evolution. Thus, regulatory 
systems that can be engineered are more useful for constructing more complex biological circuits 
to carry out more versatile biological functions. 
 
1.3.2 RNA-only regulatory systems 
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 Besides riboswitches which can regulate gene expression by binding with ligand 
molecules, RNA-only regulatory elements were also discovered in natural systems, such as 
antisense-RNA80. Antisense-RNA regulates gene expression by binding with its complementary 
sequences located in mRNAs. Binding of antisense-RNA will cause conformational changes in 
the target mRNA, which then exhibit different biological functions. In transcriptional-level 
regulation, antisense-RNA can regulate the formation of transcriptional terminator to regulate 
gene expression (Fig. 1.6A). Without antisense-RNA binding, the terminator sequence will be 
disrupted in a large stem-loop structure during transcription, so no transcription termination can 
occur. When antisense-RNA binds with its targeting sequence from mRNA, the large stem-loop 
structure will not form during transcription, which facilitates the formation of transcriptional 
terminator to terminate gene transcription. At translational-level, gene regulations are occurred at 
RBS domain68,81. Without antisense-RNA, RBS domain will stay in a linear structure, which is 
accessible to the binding of ribosomes (Fig. 1.6B). But when antisense-RNA binds with its target, 
the RBS domain will be sequestered into a hairpin structure, and gene expression is also being 
blocked. Another mechanism for antisense-RNA regulation is by directly binding with RBS 
domain through loop-linear interactions (Fig. 1.6C). 
 Inspired by those natural regulatory systems, researchers designed and engineered 
different RNA-based regulatory systems that can function in either transcriptional or translational 
levels. 
 
1.3.2.1 Transcriptional level designs 
 By engineering the antisense-RNA and its target sequence82, researchers got different 
RNA-based regulatory elements (Fig. 1.6D&E). But these mutated types usually exhibit less 
regulating efficiency compared with their wild-type versions, which can exhibit around 5-fold 
change in gene expression levels. To improve the regulating efficiency, Meyer et al. developed 
one type of small transcription activating RNAs (STARs) that directly bind with terminator 
sequences to disrupt its structure during transcription49 (Fig. 1.7A). And with this design, the fold 
change of gene regulation can reach up to about 15-fold. Westbrook et al. further improved the 
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design into a dual-level regulation systems, in which regulation occurs at both transcriptional and 
translational levels83 (Fig. 1.7B). With this updated regulating mechanism, the fold change of the 
system is elevated to over 900-fold. 
 However, although the transcriptional designs show great improvement in fold change of 
gene expression, a fundamental limitation of these designs is the sequence constraints of their 
antisense-RNAs, since those RNAs need to contain complementary sequences with 
transcriptional terminators, whose sequences are completely predefined. This is an avoidable 
obstacle for engineering those systems into more complex biological circuits. 
 
1.3.2.2 Translational level designs 
 Inspired by natural translation regulatory systems, Isaacs et al. developed an engineered 
riboregulator47 (Fig. 1.8A). In the design, RBS domain is blocked in a hairpin structure, which can 
prevent it from binding with ribosome, so the system is in its ‘OFF’ state. When the trans-
activating RNA (taRNA) is induced, the hairpin structure will be disrupted, and RBS domain can 
also be released. In this case, the ribosome can bind with the RBS domain to translate the 
downstream gene into protein. This protein expressing state is termed the ‘ON’ state. However, 
several limitations of this design hindered its further applications. First limitation is the sequence 
constraints in the taRNA. Although this design is the first engineered riboregulator, it still cannot 
be engineered with completely random sequences for raRNAs, since there are two main 
sequence constraints located in their binding domains. One is the RBS sequence in the stem, the 
other one is the YUNR motif (pYrimidine-Uracil-Nucleotide-puRine) located in the hairpin loop. 
This in turn restricted the sequence space of the taRNA designs, which hindered its applications 
into constructing more complex biological circuits or in RNA detections. Second, binding between 
crRNA and taRNA are initiated by the binding of taRNA with the short loop from the crRNA. Since 
the loop size in this design is very short, only 6 nucleotides (6 nts) long, the driving force of their 
binding is quite weak, which resulted in low dynamic range. The best design exhibit less than 15-
fold ON/OFF ratio, weaker than the transcriptional designs talked above. 
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 To overcome those limitations, Green et al. designed a new kind of riboregulator, named 
the toehold switch84. In this design, RBS domain is moved to the top loop of a hairpin structure 
(Fig. 1.8B), and start codon is also blocked in the hairpin. Although the start codon locates in the 
stem part, which is covered by binding domain, a large bulge is designed in its complementary 
strand, so there are completely no sequence constraints for trigger RNA designs. The binding 
between switch and trigger RNAs are initiated by a linear-linear interaction occurred from the 
binding between the trigger RNA and the toehold part of switch RNA. Considering the longer 
length of the toehold part, which is over 15 nts long, the driving force for their binding is 
enormously improved. All these improvements lead to extremely high dynamic range for toehold 
switches, with the best one shows ON/OFF ratio around 660-fold. For different toehold switches, 
since there is no conserved domain in trigger RNAs, the crosstalk level between different devices 
is also extremely decreased compared with the conventional designs. 
 Toehold switch can also be engineered into sophisticated ribocomputing circuits85. By 
arrange different toehold switches in a row, a 6-input ‘Or’ logic nanodevice is successfully 
constructed (Fig. 1.8C). To carry out ‘And’ logic computation, the trigger RNA is split into few 
parts with complementary domains added onto each of them (Fig. 1.8D). When being transcribed 
together, those split triggers can bind together to form the full-length trigger to turn on the toehold 
switch. With this mechanism, a 4-input ‘And’ logic nanodevice is successfully tested. The most 
complex circuit constructed in this work is a 12-input DNF ribocomputing circuit (Fig. 1.8E). In this 
circuit, all 28 input conditions are successfully tested with clear signal differences between TRUE 
and FALSE states (Fig. 1.8F). 
 
1.4 In vitro diagnostic 
Since trigger RNAs of toehold switch do not contain any sequence constraints, toehold 
switches can be engineered to detect RNA molecules with completely random sequences. This 
leads to a major application of toehold switch, diagnostics. To get a portable and low-cost 
diagnostic platform based on toehold switch, researchers incorporated cell-free system86 onto a 
paper-based platform87 to carry out diagnostic tests88. 
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1.4.1 Cell-free system and paper-based platform 
 For cell-free system, all components, including enzymes, materials and energy source, 
which are used for transcription and translation, are either purified individually from bacteria or 
directly added into the system86. Systems of the former type include 32 components that are 
purified individually: three initiation factors (IF1, IF2, IF3), three elongation factors (EF-G, EF-Tu, 
EF-Ts), three release factors (RF1, RF3, RRF), 20 aminoacyl-tRNA synthetases (ARSs), 
methionyl-tRNA transformylase (MTF), T7 RNA polymerase, and ribosomes. In addition, some 
other necessary components are also added into the system, including 46 tRNAs, NTPs, creatine 
phosphate, 10-formyl-5,6,7,8-tetrahydrofolic acid, 20 amino acids, creatine kinase, myokinase, 
nucleoside-diphosphate kinase, and pyrophosphatase. When DNA and RNA molecules encoding 
for proteins are added into the system, expression of the proteins can be transferred from inside 
the cells to outside the cells. Paper-based platform is a small piece of filter paper disc, which is 2 
mm in diameter. Cell-free system can be freeze-dried onto the paper disk, and remain stable for 
years. Once rehydrated with water, transcription and translation of input DNA or RNA will be 
activated. 
 For paper-based diagnostic platform (Fig. 1.9A), the reporter gene that regulated by 
toehold switch is replaced with lacZ gene, which encodes for an enzyme that can cleave its 
chemical substrate to output a color change signal from yellow to purple. Cell-free systems 
together with plasmid encoding for pathogen detecting toehold switches are freeze-dried onto the 
small paper discs. When the freeze-dried paper disc is rehydrated with corresponding pathogen 
RNA, expression of the regulated lacZ protein will be activated to output a color change signal for 
detection. This platform exhibits several advantages. It does not require thermal cycler for running 
the reaction, and the color change signal can be directly discerned by eye, which does not require 
additional equipment for detecting the readout. Moreover, only targeting RNA sequence can turn 
on the color change reaction, which wipes out the possibility of getting false positive results. 
 
1.4.2 Zika virus detection 
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 The recent outbreak of Zika illustrates the need for low-cost and portable diagnostic 
platforms, which do not require expertise to manipulate and expensive instruments to implement 
for people who are living in rural areas to use. The traditional ways to detect Zika virus are 
antibody detection, qRT-PCR and isothermal nucleic acid amplification. Antibody detection 
usually outputs results very fast, but it provides limited sensitivity. Moreover, the cross-reactivity 
from other flaviviruses may result in false positive readouts89. qRT-PCR and isothermal nucleic 
acid amplification provide with more accurate diagnostic readouts since they are targeting at 
specific regions of virus genomes. However, these techniques require expensive equipment, 
reagents and experienced expertise to run the test, which may not available for people living in 
low-resource locations. 
 Paper-based diagnostic platforms provide a better pathogen detecting method. However, 
viruses in clinical urine or serum samples are usually at very low concentration, which is not 
sufficient to turn on paper-based reactions. To improve platform sensitivity, an isothermal RNA 
amplification technique termed as NASBA (nucleic acid sequence-based amplification) is 
incorporated90 (Fig. 1.9B). In NASBA, reverse transcription takes place with the binding of target 
RNA template and reverse primer to generate a DNA/RNA duplex. Then the RNase H degrades 
the RNA temple to release the ssDNA. A forward primer containing the T7 promoter initiates the 
formation of dsDNA. Then the RNA polymerase generates numerous copies of new target RNA 
templates. Those new RNA templates can react with toehold switches and can also serve as new 
templates for further amplification. To release the RNA template from virus capsid, a simple 
heating step is needed. After diluted with water and heated up to 95˚C for 2 min, sufficient RNA 
templates can be released for running NASBA (Fig. 1.9C). With this technique, Zika samples with 
clinical level virus concentrations were successfully tested. 
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Figures 
 
Figure 1.1 Toggle switch design and experimental results.  
(A) Design of toggle switch. (B) Test of toggle switch in E. coli. The grey shading indicates 
periods of chemical or thermal induction. 
  
A
B
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Figure 1.2 Oscillator design and experimental results.  
(A) Plasmids construction of oscillator systems. (B) Time course GFP fluorescence from cells. 
  
A
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Figure 1.3 Counter designs and experimental results.  
(A) The RTC two-counter design and expression profiles after arabinose pulses. 
(B) Mean fluorescence of three replicates of two-counter systems via flow cytometry. 
(C) The RTC three-counter design and expression profiles after arabinose pulses. 
(D) Mean fluorescence of three replicates of three-counter systems via flow cytometry 
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Figure 1.4 Genetic switchboard of the biocomputer circuitry. 
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Figure 1.5 Schematic of the gene regulation by TPP-binding riboswitch44.  
(A) Regulation of translation initiation. (B) Regulation of transcription termination.  
Complementary sequences are highlighted in blue, and their interactions are labeled with blue 
dashed lines. SD sequence and start codon are labeled with green. TPP and Mg2+ are marked 
with red and magenta, respectively. 
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Figure 1.6 Gene regulation by natural and engineered antisense-RNAs82.  
(A) A transcriptional attenuator located at the 5’ non-coding region of an mRNA can regulate 
gene expression at transcriptional level by regulating the formation of transcription terminators80. 
(B, C) Antisense RNA translational regulate gene expression at translational level by regulating 
the accessibility of RBS to ribosomes, with either a loop–loop interaction (B), or a loop–linear 
interaction (C). (D, E) Engineered transcription attenuators.  
A
B C
D E
	 20	
 
Figure 1.7 Small Transcription Activating RNAs (STARs)49 and dual-level activator83. 
(A) Mechanism of STARs. The terminator formed during transcription in the mRNA will stop the 
transcription process. When the STAR disrupted the terminator structure during transcription, full 
length mRNA can be successfully transcribed, so that gene expression can be turn on. 
(B) Mechanism of the transcriptional and translational dual-activator. Without STAR, terminator 
will stop mRNA transcription once formed, and the RBS domain will also be blocked in the formed 
hairpin structure. When STAR binds to its targeting domain, the terminator cannot form during 
transcription, and the RBS domain will also stay in a linear structure, which is accessible for 
ribosome binding to translate downstream proteins. 
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Figure 1.8 Toehold switch84 and derived ribocomputing designs85. 
(A and B) Design schematics of conventional riboregulators and toehold switches. 
(C) Schematic of the six-input OR gate RNA with six sensor modules. 
(D) Schematic of the input RNA interaction used in a four-input AND gate. 
(E) Schematic of the 12-input DNF expression evaluated in E. coli  
(F) ON/OFF GFP from the DNF circuit under 28 different input RNA combinations; Inset, ON/OFF 
GFP on a logarithmic scale.   
A B
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Figure 1.9 Modified toehold switch with colorimetric output87 and NASBA reaction89. 
(A) Schematic of the LacZ-expressing toehold switches used to generate colorimetric outputs.  
(B) Schematic of NASBA (nucleic acid sequence based amplification)-mediated RNA 
amplification. 
(C) Pre-heating step of clinical samples. 
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CHAPTER 2 
LOW-COST DETECTION OF NOROVIRUS USING PAPER-BASED CELL-FREE SYSTEMS 
AND SYNBODY-BASED VIRAL ENRICHMENT 
2.1 Introduction 
 Noroviruses are the leading cause of human gastroenteritis91 and globally are estimated 
to exact $60 billion in societal costs each year92. These viruses are extremely contagious93 and 
can persist in the environment on contaminated surfaces, causing frequent outbreaks in closed 
settings such as long-term health care facilities, hospitals, schools, and cruise ships91. 
Noroviruses are also the primary cause of foodborne illness94, and thus impose substantial risks 
to the food industry. Although norovirus infections are often self-limiting with symptoms that 
persist for only 48 hours in healthy individuals, the virus can lead to severe symptoms and 
prolonged illnesses in young children and the elderly91. In the United States alone, norovirus 
infections are estimated to impose an annual burden of 400,000 emergency department visits, 1 
million pediatric medical care visits, and 19-21 million total illnesses95,96. In developing countries, 
the virus is associated with poorer health outcomes and is estimated to cause over 200,000 
deaths annually97,98. 
Methods to accurately diagnose norovirus infections are thus essential to contain the 
spread of outbreaks and to ensure that patients receive optimal treatment. Noroviruses are non-
enveloped, single-stranded, positive-sense RNA viruses and they exhibit substantial genetic 
variability, which can complicate efforts to develop effective diagnostics. Over 30 norovirus 
genotypes are known to cause acute gastroenteritis in humans. Of those genotypes, the GII.4 
virus is the most commonly reported99,100, and newly evolved strains in this genotype have 
emerged to cause global pandemics roughly every two to three years since the mid-1990s91,93. At 
present, the most commonly used methods to detect norovirus are immunochromatographic 
lateral flow assays and PCR-based tests91. Immunochromatographic lateral flow assays employ 
antibodies that recognize viral surface proteins and can be advantageous since they do not 
require specialized equipment and provide test results in 15 minutes. However, these tests 
provide limited sensitivity101,102 and their results can be strongly genotype dependent91. Real-time 
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quantitative reverse transcriptase PCR (qRT-PCR) is currently the gold standard for detection of 
norovirus91. qRT-PCR assays can be targeted to conserved regions of the norovirus genome and 
they provide high specificity and sensitivity. These assays, however, require expensive thermal 
cycling equipment and are typically run in centralized laboratories103. Shipment of samples can 
delay test results and specialized laboratory equipment is often not available in developing 
countries or in remote settings, such as ships at sea, where outbreaks frequently occur. Highly 
automated commercial instruments such as the Cepheid GeneXpert have been developed for 
decentralized use103. However, these instruments are expensive. Even with negotiated prices for 
low- and middle-income countries, the GeneXpert instrument, for instance, costs $17,000 and 
has cartridges available at a concessional price of $9.98. These factors lead to an overall per test 
cost of $14.93 once labor, consumable, and other costs are included104. In the absence of 
discounts, GeneXpert costs rise substantially to $30.26-$155.44 per test depending on the 
country105. 
In response to these limitations, researchers have implemented nucleic acid tests for 
norovirus that employ isothermal amplification methods rather than conventional PCR106-116 to 
obviate the need for expensive equipment and facilitate decentralized assays. Use of isothermal 
amplification methods, such as nucleic acid sequence-based amplification (NASBA)117, loop-
mediated isothermal amplification (LAMP)118, and recombinase polymerase amplification (RPA)119, 
avoids the need for expensive thermal cyclers, and it has enabled noroviruses to be detected in 
fecal samples106-108,111-114,116, surface water109, and in oysters110,115. However, these tests have 
required additional equipment to read out assay results via fluorescence or 
electrochemiluminescence106,108,109,112,114,116, have the potential for false positives if the isothermal 
amplification is non-specific107,110,111,113,115, or rely on expensive reagents such as non-canonical 
or fluorescent DNA bases108,109,112,114,116. We have recently developed an alternative strategy for 
nucleic acid detection that employs transcription-translation cell-free reactions embedded on 
paper substrates87. These systems employ freeze-drying to preserve the activity of the cell-free 
systems for over a year at room temperature, and they can be reactivated using water to enable 
synthetic biology tools to be deployed outside the lab. In previous work, these paper-based 
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systems successfully detected the Zika virus when coupled with isothermal NASBA reactions89 
and employed programmable riboregulators called toehold switches84 to directly verify the 
sequence of the amplified RNA and produce the reporter enzyme ß-galactosidase (lacZ). This 
Zika assay was low cost at $1 to read out each test, required only inexpensive equipment, and 
provided results that could be detected directly by eye through cleavage of a chromogenic lacZ 
substrate. 
Here we report the application of the paper-based cell-free platform for the detection of 
the prevalent GII.4 Sydney norovirus genotype (Fig. 2.1). Beginning from fecal samples or a 
dilute solution containing the virus, the assay employs biotin-labelled synthetic peptide affinity 
ligands known as synbodies to capture norovirus particles and concentrate them using 
streptavidin-coated magnetic beads. A brief heating step is used to release the norovirus RNA, 
and either NASBA or reverse transcriptase RPA (RT-RPA) is employed to amplify the viral RNA. 
The amplification products are then added to paper-based cell-free reactions where norovirus-
specific toehold switches are used to verify their sequences and produce the lacZɑ peptide, which 
provides a visual reaction readout. We demonstrate that this assay enables detection of norovirus 
GII.4 Sydney from a stool sample down to concentrations of 270 aM without the use of a 
concentration step, and further show that synbody-based enrichment of the virus can lower the 
detection limit by 1000-fold to 270 zM. We also demonstrate that the use of ɑ-complementation, 
in which the lacZɑ and lacZω peptides complement to form the active lacZ enzyme, can reduce 
the time to detection of the paper-based assay by up to 23 minutes or 43% compared to 
experiments employing the full-length lacZ as the toehold switch output. These results expand the 
range of sample types and viruses that can be analyzed using paper-based cell-free systems and 
provide new strategies to improve the sensitivity and reduce the time of these inexpensive 
diagnostic assays. 
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2.2 Materials and methods 
2.2.1 Norovirus samples and bacterial strains 
Stool samples positive for the norovirus GII.4 Sydney genotype and the norovirus GI.2 
genotype were generously provided by Jan Vinjé from the National Calicivirus Laboratory at the 
Centers for Disease Control and Prevention (CDC). Escherichia coli MG1655 (ATCC, 700926), 
methicillin-resistant Staphylococcus aureus MRSA252 (ATCC, BAA-1720), and Bacillus subtilis 
168 (ATCC, 23857) were used for assay cross-reactivity experiments. For these experiments, 
RNA from the bacteria was extracted using a Quick-RNA Fungal/Bacterial Miniprep Kit (Zymo 
Research) following the manufacturer’s instructions. To obtain purified viral RNA for cross-
reactivity experiments, 5 µL of GII.4, GI.2, and GI.6 positive stool samples were suspended in 
140 µL RNase-free water. The viral RNA was extracted by using QIAamp DSP Viral RNA Mini Kit 
(Qiagen, U.S.A.) according to the manufacturer’s instructions. RNAs were eluted with 50 µL 
RNase-free water and stored at -80°C. E. coli DH5ɑ (ThermoFisher Scientific) was used for 
cloning of toehold switch plasmids. 
 
2.2.2 In silico selection of toehold switch designs 
An updated version of the selection algorithm described previously84 was used to identify 
toehold switches for detection of norovirus RNA. The algorithm facilitated selection six promising 
designs from a set of over 100 candidate toehold switches generated from each norovirus target 
RNA. Candidate devices were designed to bind to a 36-nt continuous region of the norovirus 
target RNA. Putative toehold switches were generated at 1-nt increments along the norovirus 
target RNA and multiple ensemble defect levels were computed for each sensor based on its 
deviation from the ideal secondary structure of the toehold switch. Ensemble defects were 
calculated for the toehold switch 5’ end through to the 3’ end of the hairpin (dmin_sensor), the toehold 
domain of the toehold switch (dtoehold), the binding site of the toehold switch within the target RNA 
(dbinding_site), and the toehold switch region starting with the base immediately 3’ of the target RNA 
binding site and extending 31 nts beyond the last base on the 3’ end of the hairpin (dactive_sensor). 
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The parameter dactive_sensor was intended to provide a measure of any secondary structures in the 
activated toehold switch that could interfere with translation after binding to the target RNA. 
In addition to ensemble defects, the equilibrium fraction f of target/toehold switch 
complexes in a system with equimolar concentrations of target and toehold switch RNAs was 
calculated as a measure of the affinity of the two RNAs. In practice, this parameter was almost 
always equal to 1. Designs that produced in-frame stop codons in the output gene were 
eliminated from further consideration. Each of the parameters was then normalized such that their 
maximum value across the set of putative designs for a given target RNA was equal to 1. These 
normalized parameters, designated by an overscore, were then inserted into a scoring function s: 𝑠 = 5𝑑%&'(&)* + 4𝑑-.%/0'_2'32&4 + 2𝑑6/3_2'32&4	 + 2𝑑8/3*/39_2/%' + (1 − 𝑓) 
Toehold switches displaying the lowest values of s and screened to have f > 0.9 were selected for 
experimental testing. The weighting coefficients used in the scoring function were determined 
empirically based on testing of earlier toehold switch mRNA sensor designs84,87. 
 
2.2.3 Toehold switch plasmid construction 
Plasmids and DNA templates for transcription were constructed using conventional 
molecular biology techniques. Synthetic DNA (Integrated DNA Technologies) encoding the 
norovirus-specific toehold switch sensors was amplified by PCR and inserted into plasmids using 
Gibson assembly120 with 30-bp overlap regions as described previously121. The sequences of the 
plasmids were confirmed using Sanger sequencing (DNASU Sequencing Core, Tempe). This 
table lists the source template amplified by each primer pair and indicates what plasmid was 
produced following Gibson assembly of the resulting PCR products.  
 
2.2.4 Preparation of paper-based cell-free systems 
Cell-free transcription-translation systems (NEB, PURExpress) were prepared for freeze-
drying with the following components by volume: cell-free solution A, 40%; cell-free solution B, 
30%; RNase Inhibitor (Roche, 03335402001, distributed by MilliporeSigma), 2%; chlorophenol 
red-b-D-galactopyranoside (Roche, 10884308001, distributed by MilliporeSigma, 24 mg/ml), 2.5%; 
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with the remaining volume reserved for toehold switch DNA, water, and lacZω peptide added to a 
final concentration of 2 µM. When testing the toehold switches expressed from a plasmid, the 
plasmid DNA was added to the cell-free reaction mix to a final concentration of 30 ng/µL. When 
testing toehold switches expressed from linear DNA, the DNA was added to the cell-free reaction 
mix to a final concentration of 33 nM.  
Filter paper (Whatman, 1442-042) for housing the cell-free reactions was first blocked 
with 5% bovine serum albumin (BSA) overnight. After blocking, the paper was washed three 
times in water for 5 to 10 minutes. The paper was then heated to 50°C for drying and cut into 2-
mm diameter paper disks using a biopsy punch. The disks were transferred into 200-µL PCR 
tubes and 1.8 µL of the cell-free reaction mix was applied to each disk. PCR tubes containing the 
paper disks were then flash frozen in liquid nitrogen and transferred into a lyophilizer to dry 
overnight. Measurements were performed on the resulting paper disks two to four days after the 
freeze-drying process was completed. The paper disks remained active for at least a month of 
room-temperature storage using conditions described previously87, with the systems stored under 
nitrogen, shielded from light, and in the presence of silica gel desiccation packages. 
 
2.2.5 Screening of norovirus-specific toehold switches 
Norovirus target RNA was produced using T7 RNA polymerase-based transcription 
(Epicenter, ASF3257) from linearized DNA templates. 1.8 µL of a 5 µM solution of the target RNA 
was applied to a paper disk containing the embedded cell-free system and DNA for the toehold 
switch. The progress of the cell-free reaction was then monitored in a plate reader (Biotek, H1MF) 
at 37°C in triplicate. The relative absorbance of the paper-based reactions at 575 nm wavelength 
or OD575 was calculated by taking the absorbance at 575 nm and subtracting from it the 
absorbance at 575 nm measured at the start of the reaction. This relative absorbance thus 
removes any absorbance contribution from the paper disk and the lacZ substrate chlorophenol 
red-b-D-galactopyranoside. The fold change in lacZ production rate was calculated by computing 
the rate of change in OD575 and dividing the rate obtained for the toehold switch in the presence 
of the target RNA by that obtained in the absence of the target RNA. The fold change in lacZ 
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production rate was measured after one hour of cell-free reaction for assessment of the toehold 
switches. The change in OD575 or ∆OD575 was calculated by taking the OD575 for the reaction 
with the toehold switch and the target RNA and subtracting from it the OD575 for the reaction of 
the toehold switch without the target RNA. ∆OD575 was computed after two hours of cell-free 
reaction. Errors in OD575 were determined from the standard deviation of triplicate 
measurements. Errors in fold change lacZ production rate and ∆OD575 were determined by 
adding the relative and absolute errors of OD575 in quadrature, respectively. Welch’s unequal 
variances t-test was used to calculate p-values for plate reader detection experiments with p < 
0.05 used as the cutoff to define a statistically significant result.  
 
2.2.6 Isothermal amplification of norovirus RNA 
For NASBA experiments, reaction buffer (Life Sciences, NECB-24; 33.5%), nucleotide 
mix (Life Sciences NECN-24; 16.5%), RNase inhibitor (Roche, 03335402001; 0.5%), 12.5 mM of 
each DNA primer (2%), nuclease free water (2.5%), and RNA amplicon (20%) were assembled at 
4°C and incubated at 65°C  for 2 min, followed by a 10-min incubation at 41°C. Enzyme Mix (Life 
Sciences NEC-1-24; 25%) was then added to the reaction (for a final volume of 5 µL), and the 
mixture was incubated at 41°C  for 2 hr. The amplified product was then diluted 1:6 in water and 
applied to paper disks containing the cell-free system and DNA for the toehold switch. 
RT-RPA experiments used the commercial TwistAmp Basic RT kit (TwistDx). Reactions 
were prepared by combining 10 µM forward primer (4.8%), 10 µM reverse primer (4.8%), 
rehydration buffer, RNase Inhibitor (Roche, 03335402001; 4.4%), and RNA amplicon (22%) at 
room temperature and transferring the mixture to the freeze-dried reaction pellet. After mixing, 2.5 
µL of 280 mM magnesium acetate (5%) was added to start the reaction and it was incubated at 
41˚C for 5-7 minutes. The reaction tube was then inverted vigorously 8-10 times, spun down 
briefly, and returned to incubation at 41°C for 2 hr. The amplified product was then diluted 1:6 in 
water and applied to paper disks containing the cell-free system and DNA for the toehold switch. 
	 30	
For determination of assay detection limits, NASBA and RPA reactions were run in triplicate for 
each concentration of the target RNA or virus and applied to the paper-based toehold switch 
reactions as described above. 
 
2.2.7 Synbody-based virus enrichment 
A 30-µL volume of MyOne Streptavidin C1 streptavidin-coated magnetic beads (Life 
Technologies, U.S.A.), corresponding to 2.1×108 to 3.6×108 total beads, was added to Protein 
LowBind tubes (Eppendorf, U.S.A.). The bead storage solution was removed and the beads were 
washed three times with 1 mL of PBST (0.05% Tween 20 in 1x phosphate-buffered saline). The 
beads were then blocked with 3% BSA in PBST overnight at 4°C. The following day, the beads 
were suspended in fresh 3% BSA in PBST and blocked for an additional 2 hours. The beads 
were then washed three times with PBST and suspended in 30 µL of 1x PBS (phosphate-
buffered saline) to yield a final suspension of blocked magnetic beads.  
A dilution series of virus particles ranging from 1:103 to 1:107 was prepared by first taking 
a 1-µL aliquot of a norovirus GII.4 Sydney positive stool sample, and diluting it into 1 mL of PBS. 
The resulting 1:103 sample was serially diluted by factors of ten into PBS to generate the rest of 
the dilution series. Biotin-labelled synbody122 ASU1052 was then added to a concentration of 1 
µM into each diluted sample and incubated with shaking for 1 hour at room temperature. The 
solutions were then added to the blocked streptavidin-coated magnetic beads and shaken for an 
additional 15 minutes at room temperature. The beads were washed three times with PBST and 
one time with PBS and then suspended with 50 µL water. The beads were incubated for 2 min at 
95°C to release the viral RNA for analysis. 50 µL of each stool dilution was also incubated for 2 
minutes at 95°C and used for comparison.  
For cross-reactivity testing and tests of the assay against the GII.6 genotype, 1 µL of 
GII.4, GII.6, and GI.6 positive stool samples, as well as a norovirus-negative stool sample, were 
diluted into 1 ml of PBS and followed by the synbody enrichment procedure described above.  
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2.3 Results and discussion 
2.3.1 Design of toehold switches for norovirus GII detection 
  We first identified conserved sequence regions of the norovirus GII genome suitable for 
isothermal amplification and toehold-switch-based detection. Over 400 norovirus GII complete 
and partial genome sequences were downloaded from the NCBI database and aligned. A 200-nt 
target sequence that was highly conserved across the norovirus GII genomes was identified for 
subsequent amplification and detection experiments. This conserved sequence ran from the C-
terminal region of the viral RNA-dependent RNA polymerase through to the N-terminal region of 
VP1, the major capsid protein. 
 Toehold switches for detection of the target sequence were then generated based on an 
updated design first applied to the detection of the Zika virus. The updated toehold switch design 
previously provided lower leakage compared to earlier toehold switches89 and was originally 
developed for evaluating AND logic expressions in E. coli85. As illustrated in Figure 2.2A, binding 
of a cognate target RNA to the updated toehold switch unwinds the lower half of the switch RNA 
hairpin and leaves the conserved upper stem-loop intact. This upper stem-loop is sufficiently 
weak to expose the ribosomal binding site (RBS) to enable translation to occur85. Unlike earlier 
toehold switch mRNA sensors, the updated systems do not employ an RNA refolding domain 
downstream of the start codon, which could hamper translation of the output gene. 
 Based on the modified operating mechanism of the toehold switches, we implemented an 
updated design selection algorithm to identify the toehold switches most likely to be effective at 
detecting the target RNA. This algorithm modelled the interaction of a series of toehold switches 
designed to bind along the target RNA in 1-nt increments using the NUPACK software 
package123,124. Ensemble defect levels and the affinity of the toehold switch for the target RNA 
were used to select designs most likely to perform well. Since the target RNA can be transcribed 
in either the sense or antisense direction following amplification, the top six toehold switches for 
the sense and antisense target RNAs were selected for experimental testing. 
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2.3.2 Faster RNA detection with toehold switches using ɑ-complementation of lacZ 
 In previous work using paper-based cell-free systems, the lacZ enzyme has been used 
as the output gene for the toehold switch to produce a visible test result through cleavage of a 
chromogenic substrate87,89. LacZ, however, at 3.1 kb in length is a relatively long reporter gene 
compared to alternatives such as GFP (0.75 kb) and mCherry (0.72 kb), which leads to several 
drawbacks. In particular, the longer length of lacZ means that a greater fraction of the cell-free 
system resources is consumed during transcription and translation, which weakens the output 
from the assay, and longer times are required for the protein to be synthesized and fold, which 
increases the time required for the test. 
 In response to the above limitations, we investigated using ɑ-complementation of lacZ to 
decrease assay times and strengthen output from the cell-free transcription-translation reactions. 
Alpha-complementation is a widely applied technique often used for screening cloning vectors. It 
works by dividing the lacZ enzyme into two peptides termed ɑ and ω (Fig. 2.2B). The lacZ ɑ-
peptide (lacZɑ) consists of the first 50 to 59 residues from the N terminus of lacZ and the ω-
peptide (lacZω) comprises the remaining ~970 lacZ residues. The complete lacZ must form a 
tetramer before it becomes catalytically active; however, lacZω cannot form a tetramer on its own 
as it lacks residues critical for assembly. As a result, both lacZɑ and lacZω must be expressed 
before complementation occurs and an active lacZ tetramer can assemble.  
We thus implemented toehold switches that used lacZɑ as the output protein and added 
the much larger lacZω peptide as a pre-synthesized component to the paper-based cell-free 
reactions. Since lacZɑ is encoded in 180 bp, which is only ~6% of the length of the full lacZ gene, 
translation of each lacZɑ molecule should occur faster compared to lacZ and could in principle 
impose a substantially smaller burden on the cell-free system for each active lacZ tetramer 
formed. DNA encoding the norovirus-specific toehold switches was cloned into vectors upstream 
of the lacZɑ open reading frame. Following sequence confirmation, the resulting plasmids were 
tested in paper-based cell-free reactions supplemented with lacZω, and cleavage of the 
chromogenic substrate chlorophenol red-b-D-galactopyranoside was monitored using a plate 
reader. Figure 2.2C-F shows the results of these experiments with six toehold switches named 
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S1, S2, etc., for the sense orientation of the target RNA and six toehold switches named A1, A2, 
etc., for the antisense target orientation. All of the toehold switches were tested in parallel with 
reactions in which no target RNA was present. These experiments were then used to determine 
the fold change in the lacZ production rate and the ∆OD575 for each sensor. Three of the sense 
toehold switches provided ON/OFF ratios of approximately three or more (Fig. 2.2C) and 
displayed a change in absorbance at 575 nm (ΔOD575) of at least 0.4 (Fig. 2.2D), which can be 
discerned by eye. The toehold switches for the antisense target provided better performance 
overall with ON/OFF ratios up to 12.6-fold for A1 (Fig. 2.2E) and ΔOD575 up to 0.92 for A2 (Fig. 
2.2F). Although the in silico selection algorithm successfully generated functional toehold 
switches for the two norovirus targets, we only detected appreciable correlations between the 
scoring function and the toehold switches for the antisense target. The sense target devices 
showed no correlations with the scoring function. Analysis of the experimental data indicates that 
other combinations of ensemble defect parameters coupled with different weighting factors can 
provide more accurate predictions of device performance. 
 To determine the effect of ɑ-complementation on detection speed, we took one of the 
better performing toehold switches, A2, and inserted it into a plasmid upstream of the full lacZ 
open reading frame. PCR was then used to amplify linear DNA fragments from both lacZɑ and 
full-length lacZ plasmids and equal concentrations of the two DNA products were tested in paper-
based cell-free reactions in the presence of the norovirus target RNA. We observed a substantial 
increase in the speed of the colorimetric reaction for the lacZɑ systems compared to full-length 
lacZ (Fig. 2.2G). Applying OD575 = 0.4 as the detection threshold, the lacZɑ reporter reached a 
positive result in 33 minutes compared to 56 minutes for the complete lacZ, which corresponds to 
a 40% reduction in detection time. Since both reactions reach saturation and completely cleave 
the substrate within the two-hour measurement shown in Figure 2.2G, we attribute the increased 
speed of the reaction in these conditions to the faster folding time of lacZɑ compared to lacZ, 
rather than to any decrease in the burden on the cell-free reaction caused by the shorter reporter 
protein. 
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2.3.3 Isothermal amplification using NASBA and RT-RPA 
 Since the concentrations of norovirus in stool samples from symptomatic patients range 
from ~30 aM to ~3 pM,125 the toehold switches cannot be efficiently activated by viral nucleic 
acids without an amplification step. We investigated the NASBA and RT-RPA isothermal 
amplification techniques to determine which provided the lowest limit of detection against the 
norovirus GII.4 target RNA. The six toehold switches providing the highest ON/OFF ratios were 
selected for testing with amplified RNA. Since each sensor targeted different regions within the 
conserved target sequence, we evaluated different amplification primers for each sensor. One 
primer from each pair contained a 5’ T7 promoter sequence so that the resulting amplicon could 
be transcribed into RNA for optimal detection using the corresponding toehold switch. 
 Toehold switches S2 and S6 provided the lowest detection limits in the amplification tests. 
Two-hour amplification reactions were run with synthetic norovirus GII.4 target RNAs ranging in 
concentration from 220 fM to 0.2 aM. The amplified products were then diluted seven-fold and 
applied to the toehold switch reactions. For the RT-RPA reactions, both S2 and S6 toehold 
switches could detect down to 22 fM of the norovirus RNA with colorimetric outputs that could be 
readily discerned by eye (Fig. 2.3A,B). Statistically significant concentrations as low as 2.2 fM 
could be detected from quantitative plate reader absorbance measurements for toehold switch S2 
after 3 hours and toehold switch S6 after 1 hour.  
NASBA tests provided improved detection limits compared to RPA. For toehold switch S6, 
we could discern concentrations down to 2 fM by eye within 2 hours and by plate reader within 1 
hour (Fig. 2.3C). Although toehold switch S2 was not one of the very top performers in the initial 
screen (Fig. 2.2), it provided the lowest detection limit when coupled with NASBA. Experiments 
showed this sensor could detect down to 200 aM concentrations of the synthetic norovirus 
transcript (Fig. 2.3D). In addition, the sensor enabled detection by eye in 60 minutes at the 200 
am detection limit as shown in Figure 2.3E and by plate reader in 28 minutes. A concentration of 
200 aM corresponds to 600 copies of the RNA template in the 5 µL NASBA reaction. 
 
2.3.4 Diagnostic validation with active norovirus 
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 To validate the detection platform, we performed experiments with active norovirus 
samples and tested the assay for cross-reactivity against other potential pathogens. Following 
previous reports on norovirus116,126 and our earlier work on the Zika virus89, we first evaluated a 
simple method for extracting viral RNA from infected stool samples using a brief heating step. A 
norovirus GII.4 Sydney positive stool sample was diluted 1:50 in PBS and heated for two minutes 
at 95°C (Fig. 2.4A). The same procedure was applied to a stool sample not infected with the virus 
and two additional stool samples containing norovirus GI.2 and GI.6. These heated samples, 
along with comparison unheated samples and a water-only negative control, were both amplified 
by NASBA over 2 hours and applied to a paper-based reaction with toehold switch S2. The 
unheated samples all yielded minimal changes in toehold switch output compared to the negative 
control. The OD575 of the heated sample with norovirus GII.4 Sydney increased to 1.13, while 
the OD575 of the other heated samples remained below 0.25 (Fig. 2.4B). Thus, the simple 
heating method was effective at releasing RNA from norovirus particles and the assay was 
specific for norovirus GII.4 Sydney.  
To further evaluate cross-reactivity, we extracted RNA from E. coli, B. subtilis, and a 
methicillin-resistant S. aureus (MRSA) strain and added the RNA at masses of 80.6 ng, 123.5 ng, 
and 100.8 ng, respectively, to the NASBA reaction. RNA was also extracted from stool samples 
containing norovirus GII.4 Sydney, GI.2, and GI.6 and added to the NASBA reaction at a 
concentration of approximately 20 fM. None of these samples of bacterial RNA nor the GI.2 and 
GI.6 norovirus genotypes were able to activate toehold switch S2 for visual detection. The system 
was strongly activated by norovirus GII.4 Sydney RNA (Fig. 2.4C). 
 
2.3.5 Norovirus enrichment using a synbody-based magnetic bead technique 
 The ability to identify norovirus in dilute solutions or from large solution volumes is 
valuable for improving diagnostic sensitivity and for confirming complete decontamination of an 
area following an outbreak. For instance, dilute liquids, such as cleaning solutions from kitchen 
and bathroom surfaces, can be tested for residual virus following cleanup. To this end, we 
employed a synbody-based magnetic bead capture assay to concentrate norovirus from dilute 
	 36	
solutions (Fig. 2.5A). Synbodies are synthetic bivalent affinity ligands composed of two 15- to 20-
mer peptides screened to bind to the surface of a protein of interest. Synbodies have affinities 
and specificities similar to antibodies127,128. Unlike antibodies, however, which often lose their 
affinity as norovirus strains evolve91, synbodies have broad cross-affinity for multiple norovirus 
genotypes, which enables them to recognize a range of norovirus genotypes within both the GI 
and GII genogroups122.  
To capture and concentrate the virus, we took a stool sample positive for norovirus GII.4 
Sydney at a concentration of 270 fM as determined by qRT-PCR and prepared a series of higher 
dilutions ranging from 1:103 to 1:107 in PBS. Biotin-labelled synbody ASU1052, which was 
previously validated against multiple norovirus strains122, and streptavidin-coated magnetic beads 
were added sequentially to the diluted samples with shaking at room temperature for 75 minutes 
total. After magnetic capture and washing, the beads were suspended with 50 µL of water and 
heated to 95°C for 2 min to release the virus RNA. These virus samples, along with comparison 
ones heated but not subjected to synbody capture, were then amplified using NASBA and applied 
to paper-based cell-free systems containing toehold switch S2. 
 Figure 2.5B displays the absorbance change produced from the reactions after two hours 
with the two different sets of samples. For synbody-concentrated samples, norovirus could be 
detected by eye with dilution factors up to 105, which corresponds to a concentration of 2.7 aM. In 
contrast, none of the samples used directly and not subjected to concentration could be detected 
within two hours by eye. To further compare the two preparation methods, Figure 2.5C shows the 
absorbance change over time for several virus samples. The synbody-concentrated sample 
prepared from a 105 dilution crosses the eye-based detection threshold of OD575 = 0.4 in under 
two hours and provides a statistically significant positive signal in the plate reader after 66 
minutes. The profile of the non-concentrated sample diluted 1000-fold nearly matches that of the 
synbody-concentrated sample diluted 106-fold over the full 4-hour measurement. Both samples 
cross the visual detection threshold after 3 hours and provide positive results from quantitative 
plate reader measurements in approximately 2 hours, which correspond to norovirus GII.4 
Sydney detection limits of 270 aM and 270 zM for the non-concentrated and synbody-
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concentrated samples, respectively. The synbody-based concentration technique thus enables a 
1000-fold improvement in the detection limit of the norovirus assay. 
 To determine if the assay could also be applied to closely related norovirus genotypes, 
we also tested the systems against a stool sample with the norovirus GII.6 genotype. Virus 
particles were enriched using the ASU1052 synbodies and subject to NASBA using the primers 
optimized for GII.4 Sydney amplification. Unfortunately, these primers were not effective for this 
genotype. Primers modified to match the GII.6 genome, however, enabled successful 
amplification. Despite the presence of some mismatches between toehold switch S2 and its 
binding site on the GII.6 amplicon, a visible OD575 signal was observed from paper-based 
reactions within two hours (Fig. 2.4D). Thus, toehold switch S2 is capable to detect amplicons 
from both the norovirus GII.4 Sydney and GII.4 genotypes. 
 
2.4 Conclusion 
We have demonstrated a paper-based assay for detection of norovirus that does not 
require expensive thermal cycling equipment, provides test results that can be read directly by 
eye, and employs toehold switch riboregulators to eliminate false positives caused by non-
specific amplification. The assay enables visual detection of norovirus down to a concentration of 
270 aM from clinical stool samples containing live norovirus particles from the GII.4 Sydney 
genotype. The addition of a virus capture and concentration step using synbodies enables a 
further 1000-fold improvement in the sensitivity of the assay, allowing concentrations as low as 
270 zM to be detected by eye after a three-hour paper-based reaction. This work also 
demonstrates that paper-based transcription-translation systems can remain active upon 
exposure to samples diluted from stool and confirms that RPA products can be successfully 
detected in the cell-free reactions, albeit with a higher detection limit than comparison NASBA 
products. 
The norovirus assay provides significant improvements in sensitivity compared to our 
previously reported diagnostic assay for the Zika virus89. The Zika virus test provided a 1 fM 
detection limit against synthetic target RNAs and detected the virus from plasma at a 
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concentration of 2.8 fM. In contrast, the norovirus assay demonstrated a 5-fold lower detection 
limit of 200 aM against a synthetic target and was successfully applied to a stool sample with a 
270 aM concentration of norovirus. Addition of the synbody concentration step thus yielded an 
overall 5000-fold improvement in the detection limit. The Zika virus is known to be present at very 
low levels in symptomatic patients, with serum concentrations ranging from 8 zM to 6.1 fM with an 
average of 160 aM129. These concentrations are 10- to 100-fold lower than those observed for 
patients with the related dengue and chikungunya viruses130. Accordingly, our synbody-based 
concentration methods could prove valuable for extending the existing Zika test to more carriers 
of the virus. While the Zika diagnostic was only applied to a plasma sample from a viremic rhesus 
macaque, we have also demonstrated in this work that the diagnostic platform can be used on 
human stool samples, which can be used to identify many other causes of acute gastrointestinal 
illness beyond norovirus. 
Although our norovirus assay provides sufficient sensitivity for detection from clinical 
samples, at present it requires 3-6 hours of processing time to reach a test result, which is 
substantially longer than many other diagnostics that employ isothermal amplification. We expect 
that large reductions in assay time can be obtained by further optimization of the synbody-based 
enrichment technique, by designing toehold switches optimized for quicker and stronger output, 
and by implementing new reporter proteins with faster activation. Indeed, the substantial 
decrease in reaction time that we observed using ɑ-complementation of lacZ suggests that there 
is ample room for improvement using alternative reporters. Moreover, use of faster amplification 
techniques such as RT-RPA with improved primers or strand-displacement amplification (SDA) 
could further decrease the time to detection for the technique. We also expect that toehold switch 
dynamic range against pathogen RNAs can be improved with continued refinement of in silico 
selection algorithms. In particular, screening experiments examining larger numbers of toehold 
switches against diverse target RNAs will be essential for generating in silico design scoring 
functions that are able to accurately predict their performance when deployed in cell-free 
transcription-translation systems. 
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The assay can also be improved by reducing its cost. In addition to the ~$1/test price of 
the paper-based component of the assay87, the per test costs of NASBA, streptavidin-coated 
magnetic beads, and biotinylated synbodies are $2.25, $5.38, and $0.10, respectively. The total 
cost in materials for the assay is thus $8.73 and the overall assay requires approximately 35 
minutes of hands on time. A previous study in South Africa to assess GeneXpert cartridge costs 
has reported an average lab technician salary of $9.07/hr,104 which brings the total assay cost to 
$14.02 with labor included. Materials costs for this estimate are based on retail prices for the 
components. It is likely that the quantities of magnetic beads used in the assay can be reduced 
substantially with further refinement of the experimental procedures, and materials costs can 
decrease with purchases at larger scales. Even without optimization of the assay toward reduced 
price, the total cost per assay remains lower than the $14.93 calculated for GeneXpert cartridges 
in South Africa where concessional pricing is in effect104. Furthermore, our assay does not require 
large initial expenditures for purchasing expensive equipment. 
The continual emergence of new variants of norovirus means that our paper-based assay 
will need to be updated as other strains replace GII.4 Sydney to ensure that false negatives do 
not occur. For instance, the GII.P17-GII.17 norovirus strain has recently become predominant in 
Asia100 and immunochromatographic tests, which were developed for the GII.4 strain, have 
demonstrated 1000-fold poorer detection limits against the emergent strain131. To reduce the 
probability of false negatives, our assay employs a target sequence that is well conserved across 
different GII strains, including GII.P17 and GII.17. The toehold switch S2 sensor is predicted by 
NUPACK simulations to tolerate several mismatches in the target RNA, particularly within the 
toehold region, and still expose the RBS and start codon tzo enable translation of the reporter 
gene. This resiliency against sequence variations is evidenced by the ability of device S2 to 
activate against the GII.6 strain (Fig. 2.5D). In cases where there is larger sequence divergence, 
sensor mRNAs that employ multiple toehold switch hairpins upstream of a single output gene can 
be used to detect different norovirus strains or to compensate for locations with higher sequence 
variability to avoid false negatives. We have demonstrated that such OR logic systems can be 
used to detect six completely sequence-independent target RNAs using a single sensor mRNA in 
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E. coli85. We expect that similar approaches can be used in the paper-based reactions and prove 
more parsimonious with cell-free systems resources than other implementations employing 
multiple independent mRNAs. Like other nucleic acid tests that employ amplification, false 
negatives can also occur when the amplification primers do not have sufficient homology with the 
target amplicon. Such sequence variability can be addressed using primers with degenerate 
bases at positions known to have high probability of sequence divergence. 
Despite these areas for improvement, the reasonably low cost of the assay and its 
reliance on only inexpensive equipment enables it to be implemented in decentralized contexts 
such as remote clinics or cruise ships with trained operators. Furthermore, coupling the validated 
molecular components of the assay with companion hardware for incubation and readout89 or 
liquid handling132 has the potential to substantially reduce operator training requirements and lead 
to more widespread deployment in the future. Lastly, the demonstrated ability of synbodies and 
toehold switches to bind to proteins and nucleic acids, respectively, from a variety of different 
pathogens87-84,127,128 indicates that our combined concentration and detection approach can be 
successfully applied to a diverse range of infectious agents. 
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Figures 
	
Figure 2.1 Overview of the norovirus detection assay using paper-based cell-free transcription-
translation reactions. A norovirus sample is first enriched using synbodies and viral RNA 
amplified isothermally using nucleic acid sequence-based amplification (NASBA) or reverse 
transcriptase recombinase polymerase amplification (RT-RPA). The amplified nucleic acids are 
added to paper-based cell-free reactions where norovirus RNAs are detected by sequence-
specific toehold switches. The toehold switches generate the lacZɑ peptide, which produces a 
purple-colored product after complementation with lacZω. Samples positive for norovirus can be 
identified by their purple color following the assay. 
  
	 42	
	
Figure 2.2 Detection of norovirus target RNA using toehold switches and ɑ-complementation.  
(A) Schematic of toehold switch operation in response to the target RNA. A weak stem containing 
the ribosomal binding site (RBS) is retained after target binding. This stem unwinds during 
binding of the ribosome to enable translation of the output gene.  
(B) Enzymatically active lacZ tetramer formation occurs directly for full-length lacZ, while lacZɑ 
and lacZω must first assemble via ɑ-complementation prior to tetramer formation.  
(C and D) Measurements of the fold change in lacZ production rate (C) and ∆OD575 (D) of six 
toehold switches targeting the sense orientation of the norovirus target RNA. 
(E and F) Measurements of the fold change in lacZ production rate (E) and ∆OD575 (F) of six 
toehold switches targeting the antisense orientation of the norovirus target RNA. Change in lacZ 
production rate was measured after 1 hour of cell-free reaction (C, E) and ∆OD575 was 
measured after 2 hours of cell-free reaction (D, F). 
(G) OD575 for toehold switch A2 as function of cell-free reaction time when outputting full-length 
lacZ compared to lacZɑ in a reaction supplemented with pre-synthesized lacZω. 
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Figure 2.3 Detection limit measurements for synthetic norovirus GII.4 target RNAs subject to 
isothermal amplification and detection using toehold switches. 
(A and B) OD575 after amplification using RT-RPA and detection using toehold switches S6 (A) 
and S2 (B) in two-hour cell-free reactions.  
(C and D) OD575 after amplification using NASBA and detection using toehold switch S6 (C) and 
S2 (D) in two-hour cell-free reactions. 
(E) Photographs of paper-based reactions using NASBA for amplification and toehold switch S2 
for detection. Photographs were taken after 1 hour of the cell-free reactions. 
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Figure 2.4 Detection of live norovirus GII.4 Sydney and cross-reactivity testing. 
(A)	Norovirus RNA was extracted by diluting a stool sample 1:50 into PBS and briefly heating to 
95°C for 2 minutes. 
(B) Measurement of OD575 after a two-hour paper-based reaction for a water-only negative 
control (–) and stool samples with and without norovirus particles before and after the brief 
heating treatment. All samples were subject to amplification via NASBA and detection with 
toehold switch S2. Only the heated norovirus GII.4 Sydney sample activates the toehold switch. 
(C) Cross-reactivity testing of the assay against RNA from multiple bacteria, norovirus genotypes, 
and a water-only negative control. All samples were subject to NASBA and toehold switch S2 
detection. OD575 was measured after two hours of the cell-free reaction. 
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Figure 2.5 Implementation of a synbody-based capture and concentration method for norovirus 
detection. 
(A) Illustration of the synbody enrichment technique. Biotin-labelled synbodies engineered to 
recognize diverse norovirus genotypes are used to bind to virus particles in a dilute solution and 
are in turn captured by streptavidin-coated magnetic beads. Magnetic capture enables 
concentration of the captured norovirus particles. 
(B) Measurement of OD575 after two-hour cell-free reactions with toehold switch S2. Samples 
subject to synbody-based concentration and samples used directly without concentration were 
amplified by NASBA. The negative control (–) is a water-only sample. 
(C) Time-course measurements of OD575 for synbody-concentrated samples compared to 
samples used directly. OD575 for a sample used directly after 1000-fold dilution is comparable to 
a concentrated sample initially diluted by 106-fold.  
(D) Detection of norovirus GII.6 from a stool sample using toehold switch S2 and updated NASBA 
primers for the GII.6 genome. OD575 measurements were taken after two hours of the paper-
based cell-free reaction and using a norovirus-negative stool sample as comparison. 
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CHAPTER 3 
LOOP-INITIATED RNA ACTIVATORS: HIGH-PERFORMANCE TRANSLATIONAL 
REGULATION WITHOUT SEQUENCE CONSTRAINTS 
3.1 Introduction 
 Synthetic biology unites biology and engineering9,133 with a focus on constructing novel 
biomolecular components, complex synthetic networks, and unnatural metabolic pathways in 
living cells. To date, a number of biological devices have been constructed, including toggle 
switches10, oscillators11, molecular counters134, logic gates23,135-137, cell classifiers138 and analog 
signal processors139. Yet efforts to create more complex devices have been hindered by the 
limited number of effective components that have high dynamic range and low crosstalk, 
especially when being put into the complex cellular environment9. 
 RNA based components are an attractive means to construct more complex circuits since 
they can take advantage of predictable Watson-Crick base pairing and exploit the numerous RNA 
based gene regulation systems have been found in nature140-142. Indeed, researchers have 
created many engineered RNA riboregulators based on natural systems143-148 that regulate 
transcription or translation upon detection of a target RNA. However, these systems have been 
limited in their dynamic range and their orthogonality. More recently, de novo designed 
riboregulators called toehold switches have been developed that can provide ON/OFF ratios over 
600-fold and exhibit very low crosstalk levels across dozens of different devices84. Although these 
performance metrics represent substantial improvements over previous riboregulators, toehold 
switches do suffer from a number of important limitations. First, they exhibit noticeable signal 
leakage in vivo, which limits their use in applications requiring very stringent regulation of gene 
expression. Second, they impose restrictions on the sequence of the target RNA to be detected 
and the residues incorporated into the output gene. 
 We have recently developed a new type of synthetic riboregulator inspired by molecular 
beacons149 that overcomes many of the limitations of toehold switches. These loop-initiated RNA 
activators (LIRAs) mechanism between a repressed mRNA containing a stem-loop and a single-
stranded cognate target RNA. Testing of the LIRAs in E. coli has demonstrated that these 
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systems provide high dynamic range, low crosstalk and extremely low leakage in vivo. LIRAs can 
also be engineered to detect RNAs with arbitrary sequences, since no correlated domains with 
predefined sequences located in the trigger RNA binding region. By incorporating with paper-
based diagnostic platform, LIRA realized the detection of viruses down to 20 aM, which is equal 
to 12 copies/µl. 
 
3.2 Materials and methods 
3.2.1 Strains and growth conditions 
 The following E. coli strains were used in this study: BL21 Star DE3 (F− ompT hsdSB 
(rB−mB−) gal dcm rne131 (DE3); Invitrogen), BL21 DE3 (F− ompT hsdSB (rB−mB−) gal dcm 
(DE3); Invitrogen), MG1655Pro (F− λ− ilvG- rfb-50 rph-1 SpR lacR tetR), and DH5α (endA1 
recA1 gyrA96 thi-1 glnV44 relA1 hsdR17(rK−mK+) λ−; Invitrogen). All strains were grown in LB 
medium at 37 °C with appropriate antibiotics. 
 
3.2.2 Plasmid construction 
 Plasmids were constructed by PCR and Gibson assembly techniques. Single-stranded 
DNAs for expressing LIRAs and target RNAs were purchased from Integrated DNA Technologies 
and amplified into double-stranded DNA via PCR. The amplified DNAs were then connected with 
plasmid backbones by 30-bp homology domains using Gibson assembly120. All Gibson assembly 
products were transformed in the E. coli DH5α strain and then sent out for sequence validation 
via Sanger sequencing. Backbones used for constructing the plasmids were amplified from the 
commercial vectors pET15b, pCOLADuet via PCR followed with Dpn1 treatment. The reporter 
protein for all plasmids is GFPmut3b with an ASV degradation tag. 
 
3.2.3 Flow Cytometry Measurements and Analysis 
 Bacteria colonies transformed with LIRA and target RNA plasmids are inoculated in 1ml 
LB in triplicates with corresponding antibiotics. On the second day, 5ul overnight cultured medium 
is diluted by 100 folds in 495ul fresh LB with 60% kanamycin, 50% ampicillin and 50% 
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spectinomycin. After 80mins recover, IPTG is added into each well with a final concentration of 
0.1mM. And flow cytometry measurement is performed after 3, 4 and 5hours inducement. 
 Flow cytometry was performed using a S1000 cell analyzer (Stratedigm) equipped with a 
high-throughput auto sampler (A600, Stratedigm). Before running measurement, cells were 
diluted by ~10 folds into phosphate buffered saline (PBS) in 384-well plates. Forward scatter 
(FSC) was used for trigger, and 40,000 individual cells were recorded. Cell populations were 
gated according to their FSC and side scatter (SSC) distributions as described previously. The 
GFP fluorescence signal outputs of these gated cells were used for following calculations. Error 
levels for the fluorescence measurements of ON state and OFF state cells were calculated from 
the SD of measurements from at least three biological replicates. The relative error levels for the 
ON/OFF fluorescence ratios were then determined by adding the relative errors of ON and OFF 
state fluorescence in quadrature. 
 
3.2.4 Cell-Free Reactions 
 Cell-free transcription-translation systems (NEB, PURExpress) were prepared for freeze-
drying according to following recipe: cell-free solution A, 40%; cell-free solution B, 30%; RNase 
Inhibitor (Roche, 03335402001, distributed by MilliporeSigma), 2%; chlorophenol red-b-D-
galactopyranoside (Roche, 10884308001, distributed by MilliporeSigma, 24mg/ml), 2.5%; with the 
remaining volume reserved for LIRA DNA, water and lacZα peptide added to a final concentration 
of 2 µM. When testing LIRA expressed from a plasmid, the plasmid DNA was added to a final 
concentration of 30ng/µl to the cell-free reaction mix. 
 Filter paper (Whatman, 1442-042) for deposit and freeze-drying the cell-free system was 
first blocked with 5% bovine serum albumin (BSA) overnight. The paper was washed three times 
in water for 5 to 10 min after overnight blocking. The paper was transferred on a hot plate at 50˚C 
for drying and then cut into 2mm diameter paper disks with a biopsy punch. The disks were then 
transferred into 200µl PCR strips and 1.8µl of the above cell-free reaction mix was applied to 
each of them. Liquid nitrogen was used for freeze the PCR strips containing those paper devices. 
The frozen paper disks were dried overnight with a lyophilizer. Plate reader tests were carried out 
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on the freeze-dried paper disks 2-4 days later. With the systems stored in nitrogen environment, 
shielded from light and together with the silica gel desiccation packages as described previously, 
the paper disks remained active for at least a month under room temperature. 
 
3.2.5 NASBA 
 NASBA experiments were carried out following the standard protocols: reaction buffer 
(Life Sciences, NECB-24; 33.5%), nucleotide mix (Life Sciences NECN-24; 16.5%), RNase 
inhibitor (Roche, 03335402001; 0.5%), 12.5 µM of each DNA primer (2%), nuclease free water 
(2.5%) and RNA amplicon (20%) were assembled at 4˚C. After being incubated at 65˚C for 2 min 
and a 10 min incubation at 41˚C, 1.25µl enzyme Mix (Life Sciences NEC-1-24; 25%) was added 
to the reaction. The reaction took place at 41˚C for 2 h and was then diluted 1:6 into water before 
applying to the freeze-dried paper devices. 
 
3.2.6 qRT-PCR test 
 Primers are designed for both GFP gene and 16s rRNA which used as interval control. 
Bacteria colonies transformed with cognate and non-cognate LIRA and trigger plasmids are 
inoculated in 6ml LB in triplicates with corresponding antibiotics. All RNAs in bacteria are 
extracted with commercial RNA miniprep kit (Zymo Research, R2014) following the standard 
protocol in the manual. Reverse transcription is performed using the commercial kit (Qiagen, 
205311) with the protocol from the manual. PCR is taken place with commercial kit (Life 
Technologies, 4367659) and measured by the Mx3005P qPCR system. 
 
3.3 Results and discussion 
3.3.1 LIRA design and validation in vivo 
 A LIRA is a RNA molecule with a hairpin structure comprised of a large loop and a long 
stem (Fig. 3.1A). Gene expression from the switch RNA is turned off initially because the 
ribosome binding site and initial codons of the output gene are enclosed within the duplex of a 
stem-loop structure. Importantly, the size of the loop in this stem-loop structure is substantially 
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increased to 21-nts, which is much longer than the conventional loop-mediated riboregulator 
designs. This large loop provides a large initial docking site for the cognate trigger RNA, 
facilitating the binding of the trigger RNA and enabling favorable reaction kinetics, which can lead 
to high dynamic range in ON/OFF ratios. When a trigger RNA is present in the cell, it binds to the 
exposed bases in the switch RNA loop and proceeds to hybridize with bases within the stem. As 
this hybridization occurs, the newly formed RNA duplex between the trigger and switch RNA acts 
as a molecular crowbar that causes the remaining base pairs in the stem to break apart. This 
stem disruption exposes the ribosome-binding site and initial codons of the output gene, enabling 
translation of the downstream gene. 
 The stem length of the LIRA is 27 nucleotides (nt) without considering the clamp domain, 
which is the base paired domain in the bottom stem below the start codon. This domain is named 
‘clamp’ because it can help to lock and seal the start codon within the hairpin structure to prevent 
signal leakage, when no cognate trigger RNA is present. To insure LIRAs provide low signal 
leakage at ‘OFF’ state, we designed a series of LIRAs with 0, 3, 6 and 9 base pair (bp) clamps. 
Testing with flow cytometry, although at least one device of each design exhibits high ON/OFF 
ratios, the devices from 6 bp designs provided the highest ON/OFF ratios in general (Fig. 3.1B). 
We thus set 33 nt as stem length and designed 24 different LIRAs via NUPACK. 
 Those 24 LIRAs were transformed into E. coli BL21 star DE3 together with cognate or 
non-cognate trigger plasmids and validated by flow cytometry. 16 out of 24 devices exhibit 
ON/OFF levels over 50-fold, in which 8 of them are over 100-fold, with the highest one reach up 
to ~350-fold (Fig. 3.1C). The fraction of LIRA designs with ON/OFF > 100 reaches up to around 
33%, much higher than the first-generation toehold switches, in which only ~12% devices 
provided ON/OFF ratios over 100-fold. We expect that further improvements in ON/OFF levels 
can be obtained from refinements to the LIRA design parameters, for instance through increased 
loop domain size to increase the thermodynamic driving force and reaction kinetics, and more 
stringent screening of the secondary structure of the activated trigger/switch complex. 
 Besides dynamic range, crosstalk level is another considerable parameter to evaluate 
design strategies, since low crosstalk devices are more likely to be effective for constructing 
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complex genetic circuits. To test the orthogonality of LIRAs, we selected 16 designs having 
relatively high ON/OFF ratios and tested all 256 pairwise combinations of switch and trigger 
RNAs. We used flow cytometry to quantify GFP output from all switch-trigger combinations in 
triplicate measurements (Fig. 3.1D). Only cognate pairs of LIRAs and RNA triggers provided the 
highest signal output compared with all the other non-cognate combinations. 
Since there are no sequence constraints for trigger RNA sequences, LIRAs thus can be 
designed to detect arbitrary mRNAs in principle. We designed several mRNA sensors based on 
one of the high-performance devices. With cognate mRNA triggers, strong GFP signal output was 
detected in most cases (Fig. 3.1E). This demonstrated that LIRAs can be designed into mRNA 
sensors to detect mRNAs with completely arbitrary sequences in vivo. 
 To demonstrate LIRA is compatible with promoters other than T7 promoter and can 
function well in other bacteria strains, instead of only in E. coli star DE3. We further validated 
LIRA regulated by different promoters in several other bacteria strains. We tested LIRA #20 with 
four different promoters in four different bacteria strains, most of them exhibit high dynamic range 
and low-leakage in flow cytometry tests (Fig. 3.1F). This demonstrates that LIRA can be 
engineered to function in different cellular environments with excellent performance. 
 Compared with toehold switches, LIRAs exhibit several advantages. First, since the 
trigger RNA does not interact with the bottom of the switch RNA stem, LIRAs completely 
decouple the sequence of the trigger RNA from the bases encoding the output protein. In contrast, 
toehold switches add at least three undesirable residues to the output gene between the start 
codon and the linker sequence. These residues can affect output protein folding and stability. 
Second, the LIRA interaction mechanism results in a system in which a similar number of base 
pairs exist before and after formation of the trigger/switch complex. This balance in base pairing 
between these two states results in very sensitive thermodynamics that can be exploited for 
improved device to device orthogonality150. Toehold switches, on the other hand, always gain 
multiple base pairs upon hybridization to the toehold domain, and thus exhibit less sensitive 
thermodynamics. 
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3.3.2 Extremely low leakage in vivo 
 During the experimental validation, we observed that the ‘OFF’ state of most LIRAs 
provided extremely low leakage compared with the ‘OFF’ state of several toehold switches, and is 
almost the same as cell autofluorescence (Fig. 3.2A). Rho-independent transcriptional 
terminators in prokaryotes feature long stem-loop structures that interfere with the progress of the 
RNA polymerase to halt transcription. While toehold switches have relatively weak stems 15-bp 
long with a 3-nt bulge, LIRAs have far stronger stems up to 33-nts in length. Given the strength of 
this stem, we hypothesized that transcriptional regulation could be playing a role in the ultralow 
leakage we observed in the LIRAs. Thus, we performed qRT-PCR studies on both LIRA #1 and 
toehold switch N56 to determine the concentrations of the switch RNAs in vivo. We used 16s 
rRNA as the internal marker for the measurements. At first, we induced the expression of both 
cognate and non-cognate pairs of switch and trigger for LIRA #1 and toehold switch N56 using 
three colonies for each. After induction for 3 hours, we performed RNA minipreps to extract 
cellular RNAs and used reverse transcription to generate cDNA. 
 Based on the signal curves of SYBR Green from LIRA #1, we can see that expression 
levels of the housekeeping rRNA are stable for both cognate and non-cognate pairs, but GFP 
mRNA expression levels are significantly different (Fig. 3.2B). For the cognate RNAs, CT value of 
GFP cDNA is 18, but it is 20 for non-cognate pair (Fig. 3.2C). For toehold switch N56, CT values 
for both cognate and non-cognate pairs are 18. The relative gene expressions of different qPCR 
templates are shown in Figure 3.2D. According to Figure 3.2D, toehold switch N56 does not 
exhibit regulation at the transcriptional level since the cognate and non-cognate pairs show the 
same expression levels of GFP transcripts. However, for LIRA #1, cells expressing the cognate 
trigger/switch pair have 4 times more GFP transcripts than those expressing non-cognate RNA. 
The relative gene expression levels indicate that LIRAs employ regulation at the transcriptional 
level. As shown in Figure 3.2D, the CT values of GFP transcripts for the cognate pair of LIRA #1 
and toehold switch N56 are the same, indicating no regulation in transcriptional level occurs when 
cognate pair of switch and trigger appear. 
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 We propose that the trigger RNAs can bind to the newly transcribed switch RNA before 
the formation of the stem-loop structure. This binding will facilitate the transcription of the whole 
switch RNA including the downstream GFP gene. However, for non-cognate switch and trigger 
RNAs, the trigger RNA cannot bind to the newly transcribed switch RNA and the RNA 
polymerase will be displaced from the DNA due to the formation of the stable stem-loop structure. 
This finding demonstrates that LIRAs has both transcriptional and translational level regulation. 
 
3.3.3 Paper-based diagnostic with LIRA 
 The recent outbreak of Zika prompts the need of low-cost and portable diagnostic 
platforms, which do not require expertise to manipulate and expensive instruments to implement 
for people living in rural areas. The traditional ways to detect Zika virus are antibody detection, 
qRT-PCR and isothermal nucleic acid amplification. Antibody detection usually outputs readout 
very fast, but it provides limited sensitivity. Furthermore, the cross-reactivity from other 
flaviviruses may result in false positive readouts89. qRT-PCR and isothermal nucleic acid 
amplification provide with more accurate diagnostic readouts since they are targeting at specific 
regions of virus genomes. However, these techniques require expensive equipment, reagents 
and experienced expertise to run the test, which may not available for people living in low-
resource locations. 
 Paper-based cell-free systems are a portable and low-cost diagnostic platform for 
detecting viruses with high sensitivity (Fig. 3.3A). They do not require thermal cycling equipment 
for running the reaction, and the color change signal can be directly discerned by eye, which does 
not require additional equipment for detecting the readout. For constructing the paper-based 
diagnostic platform with LIRA, bacterial cell-free systems together with plasmid encoding for 
pathogen detecting LIRAs are freeze-dried on a small piece of filter paper disc, which is 2 mm in 
diameter. When the freeze-dried paper disc is rehydrated with corresponding trigger RNAs, 
transcription of the synthetic gene network and expression of the regulated reporter protein will be 
activated to output a color change signal for detection. To improve the performance of LIRA, we 
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designed a 5’ hairpin reconfiguration domain to stabilize the ‘ON’ state structure, after the hairpin 
structure is disrupted by the cognate trigger RNAs (Fig. 3.3B). 
 The pathogen detecting riboregulators displayed high specificity toward their synthetic 
virus RNA targets with a final concentration of 5 µM (Fig. 3.3C). However, viruses in clinical urine 
or serum samples are not sufficient to turn on paper-based reactions. To improve the detection 
sensitivity, an isothermal RNA amplification technique termed NASBA (nucleic acid sequence-
based amplification) was incorporated90 (Fig. 3.3D). In NASBA, reverse transcription takes place 
with the binding of target RNA template and reverse primer to generate a DNA/RNA duplex. Then 
the RNase H degrades the RNA temple to release the ssDNA. A forward primer containing T7 
promoter initiates the formation of dsDNA. Then the RNA polymerase generates numerous 
copies of new target RNA templates. Those new RNA templates can react with LIRA and can 
also serve as new templates for further amplification. To release the RNA template from virus 
capsid, a simple heating step is needed. After diluted with water and heated up to 95˚C for 2min, 
sufficient RNA templates can be released for running NASBA. 
 With NASBA, synthetic RNA templates of Norovirus, YFV with concentrations of 200aM 
and clinical DENV sample are all successfully detected (Fig. 3.3E). With respect to the clinical 
DENV sample, we diluted the human serum sample by 10 fold with water and heated it up to 
95˚C for 2min before transferring it to NASBA reaction. The total process only takes 3 hours, 2 
hours for NASBA reaction and 1 hour for color change reactions. To find out the detection limit of 
riboregulator based virus sensors, we tested DENV sensor with NASBA products from serial 
diluted synthetic DENV RNA target ranges from 200 fM to 0.2 aM. And this platform realized the 
detection of DENV RNA down to 20aM, which equals to 12copies/µl (Fig. 3.3F). 
 
3.3.4 Stem Variants of LIRA 
 Toehold switches add at least three amino acids between the start codon and the linker 
region of the regulated gene, which could have deleterious effects on the final output protein. In 
contrast, no linker is needed and no additional amino acids are required for LIRAs. However, 
there are six nucleotides located after the start codon in LIRA to help maintain the system at OFF 
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state when no cognate trigger RNA appears. We term this 6-nt a ‘clamp’ as it is designed to 
clamp down on leakage from the devices. We hypothesized that since the clamp does not interact 
directly with the trigger RNA, it should be possible to use the first 6 nucleotides of any gene as a 
successful clamp. To test this hypothesis, we designed 4 new variants from LIRA #1. These four 
switches have the same sequence as #1, but the clamp sequences are randomly designed. Then 
we transformed each switch with cognate trigger #1 and each switch with one non-cognate trigger 
into E. coli and measured the GFP output after inducing by IPTG. The ON/OFF ratios from the 
mode GFP fluorescence value measured by flow cytometry are shown in Figure 3.4A. 
 As Figure 3.4A shows, although variance exists in the output signals of each switch-
trigger combination, all systems are effectively turned on with ON/OFF > 50. Based on Figure 
3.4B and 3.4C, output variance are resulted from ON states, since all OFF states are almost the 
same. The high ON/OFF ratios indicate that clamp has no sequence constraints and thus 
reasonable performance can be expected for LIRAs regulating diverse output genes. We also 
designed four switches with different clamps from LIRA #5, and they too exhibit similar 
performance. Therefore, with no sequence constraints of the clamp, we can use the first 6 
nucleotides of any gene as clamp. We attribute the observed variation in output from the LIRAs to 
changes in the secondary structure of the trigger/switch activated complex, which can affect 
translational efficiency, and the effect of the changes in clamp sequence to the folding of the 
output GFP. 
 
3.3.5 Loop-initiated RNA repressors 
 All the above riboregulators are designed for turning on expression of regulated genes by 
binding with the trigger RNA. However, to precisely control gene expression and make more 
complex genetic circuits, another type of riboregulator termed ‘repressor’ has been studied by 
many researches151. For repressors, gene expression is initially in its ‘ON’ state. As is shown in 
Figure 3.5A-B, RBS domain and AUG start codon are located at a linear structure in upstream of 
regulated gene, so the regulated GFP gene can be translated initially. In the hairpin structure, we 
rationally designed a domain that is completely complementary to RBS domain. To weaken the 
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transcriptional-level regulation observed in LIRAs, we designed a structure containing two small 
hairpins, each of the hairpins has a relatively shorter stem. For the designs shown in Figure 3.5A 
and 3.5B, the first hairpin is 21 nts in length and the second one is 14 nts in length. The design in 
Figure 3.5B has a 12 nts 5’ toehold domain, which is designed for enhancing the transcription of 
the whole switch RNA. The data of the best device from each design is shown in Figure 3.5C, 
which can achieve over 12-fold repression. 
 
3.4 Conclusion 
LIRAs are a new type of translational regulator that exploit an effective loop-mediated 
interaction with the trigger RNA. These de-novo-designed riboregulators provide high dynamic 
range, low crosstalk and extremely low leakage in vivo. Since no correlated domains with 
predefined sequences located in the trigger RNA binding domain, LIRAs can be engineered to 
detect RNAs with completely arbitrary sequences. By incorporating with paper-based diagnostic 
platform, LIRA realized the detection of viruses down to 20aM, which is equals to 12 copies/µl. 
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Figures 
 
Figure 3.1 Structure and in vivo validation of LIRAs. 
(A) Structure and interaction mechanism of LIRA; (B) Flow cytometry measurement of LIRA 
designs with different clamp length; (C) ON/OFF ratios of 24 different riboregulators; (D) 
Orthogonal test for 16 pairs of riboregulators and trigger RNAs; (E) In vivo test of LIRA based 
mRNA sensors; (F) LIRA tests in different bacterial strains with different promoters. 
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Figure 3.2 Extremely low leakage of LIRAs in vivo. 
(A) Leakage comparison of toehold switches and LIRAs; (B) qRT-PCR test of LIRA #1; (C) Cycle 
threshold (CT) values of 16S rRNA and GFP mRNA in different conditions; (D) Delta CT value of 
each codition. 
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Figure 3.3 Pathogen-detecting LIRAs with paper-based diagnostic platform. 
(A) Schematic of paper-based diagnostic platform; (B) Design of pathogen detecting LIRAs; (C) 
Synthetic RNA detection, photos were taken after 80mins; (D) Schematic of NASBA process; (E) 
NABSA product detection, photos were taken after 1.5 hours for YFV and Norovirus detection, 2 
hours for DENV clinical sample detection; (F) Detection limit test of DENV sensor, photos were 
taken after 1.5 hours. 
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Figure 3.4 LIRA clamp variant test. 
(A) ON/OFF ratios for the four switches designed from LIRA #1. All four switches have the same 
cognate trigger; ON state were measured from cognate pairs of switch and trigger; OFF states 
were measured from non-cognate pairs of switch and trigger; (B) ON state/Cell autofluorescence 
ratios for the four switches designed from LIRA #1. ON state were measured from cognate pairs 
of switch and trigger; (C) OFF state/Cell autofluorescence ratios for the four switches designed 
from LIRA #1. OFF states were measured from non-cognate pairs of switch and trigger. 
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Figure 3.5 Different repressor designs and in vivo validation. 
(A-B) Two different types of rationally designed beacon repressors; (C) The data of best devices 
from each of those two type designs, ON state and OFF state respectively (left) and ON/OFF 
ratios (right).  
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CHAPTER 4 
LIRA-BASED RIBOCOMPUTING DESIGNS 
4.1 Introduction 
 Researchers have developed numerous genetic circuits with logic computing functions 
aiming at diverse applications16,18,21,23,24,32,56,152,153. Those genetic circuits were designed with 
creative ideas and took advantages of versatile interactions among different biological parts, 
which can fulfill their design purposes effectively. However, those logic circuits were usually 
designed with multiple layers, and need to incorporate numerous proteins or enzymes, which 
requires extensive resources for carrying out logic computing functions. Moreover, the limited 
number of orthogonal biological parts is still a challenge for constructing more complicated 
genetic circuits. RNA-only nanodevice is a promising design to overcome those limitations 
because of their high programmability. With the predictable base-pairing rules, complex 
structures with logic computing functions could be designed in silico with versatile software and 
online servers, such as NUPACK. As a single-layer device, input transduction, computation and 
signal output are all implemented in a self-assembled RNA molecule, which improves the 
processing efficiency of genetic circuits. 
 Recently, toehold switch based RNA-only nanodevices with diverse logic computing 
functions were developed85. The de-novo-designed single layer, RNA-only nanodevice, can be 
designed to carry out multiple sophisticated logic computations in vivo. By arranging six different 
toehold switches in a row, ‘Or’ logic nanodevices with up to six different inputs are successfully 
constructed. However, the output protein of each input is different, since the RBS domains 
located in upstream hairpins can initiate the translation of downstream toehold switches into 
peptides attached to the reporter protein, which may interfere with proper protein function. 
Moreover, the arrangement of several toehold switches in a row leads to higher protein 
expression levels for downstream hairpins compared with the upstream ones, since the strong 
hairpin secondary structures can impede the translating ribosome. For designing ‘And’ logic 
nanodevices, the trigger RNA is evenly split into several parts with complementary domains 
added onto each of them. When being transcribed together, those split triggers can cooperatively 
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interact with each other to form the full-length trigger, which then binds with toehold switch to turn 
on gene expression. With this mechanism, ‘And’ logic nanodevice with up to four different inputs 
were successfully tested, but those split RNA inputs are not independent, which hinders its 
applications for RNA detection and further genetic circuit constructions. 
 To overcome those limitations, we developed LIRA-based ribocomputing nanodevices 
with logic-computing functions. By rationally fusing multiple LIRAs into one nanodevice and 
arranging the positions of RBS and start codon, ribocomputing nanodevices with ‘Or’ and ‘And’ 
logic operations were successfully constructed and validated in Eschericia coli and paper-based 
cell-free systems. 
 
4.2 Methods and materials 
4.2.1 Strains and growth conditions 
 The following E. coli strains were used in this study: BL21 Star DE3 (F− ompT hsdSB 
(rB−mB−) gal dcm rne131 (DE3); Invitrogen), BL21 DE3 (F− ompT hsdSB (rB−mB−) gal dcm 
(DE3); Invitrogen), MG1655Pro (F− λ− ilvG- rfb-50 rph-1 SpR lacR tetR), and DH5α (endA1 
recA1 gyrA96 thi-1 glnV44 relA1 hsdR17(rK−mK+) λ−; Invitrogen). All strains were grown in LB 
medium at 37 °C with appropriate antibiotics. 
 
4.2.2 Plasmid construction 
 Plasmids were constructed by PCR and Gibson assembly. Single-stranded DNAs for 
expressing logic gate and target RNAs were purchased from Integrated DNA Technologies and 
amplified into double-stranded DNA via PCR. The amplified DNAs were then connected with 
plasmid backbones by 30-bp homology domains using Gibson assembly. All Gibson assembly 
products were transformed in the E. coli DH5α strain and then sent out for sequence validation 
via Sanger sequencing. Backbones used for constructing the plasmids were amplified from the 
commercial vectors pET15b, pCOLADuet, and pCDFDuet (EMD Millipore) via PCR followed with 
Dpn1 treatment. The reporter protein for all plasmids is GFPmut3b with an ASV degradation tag. 
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4.2.3 Flow Cytometry Measurements and Analysis 
 Bacteria colonies transformed with logic gate and target RNA plasmids are inoculated in 
1ml LB in triplicates with corresponding antibiotics. On the second day, 5ul overnight cultured 
medium is diluted by 100 folds in 495ul fresh LB with 60% kanamycin, 50% ampicillin and 50% 
spectinomycin. After 80mins recover, IPTG is added into each well with a final concentration of 
0.1mM. And flow cytometry measurement is performed after 3, 4 and 5 hours inducement. 
 Flow cytometry was performed using a S1000 cell analyzer (Stratedigm) equipped with a 
high-throughput auto sampler (A600, Stratedigm). Before running measurement, cells were 
diluted by ~10 folds into phosphate buffered saline (PBS) in 384-well plates. Forward scatter 
(FSC) was used for trigger, and 40,000 individual cells were recorded. Cell populations were 
gated according to their FSC and side scatter (SSC) distributions as described previously. The 
GFP fluorescence signal outputs of these gated cells were used for following calculations. Error 
levels for the fluorescence measurements of ON state and OFF state cells were calculated from 
the SD of measurements from at least three biological replicates. The relative error levels for the 
ON/OFF fluorescence ratios were then determined by adding the relative errors of ON and OFF 
state fluorescence in quadrature. 
 
4.2.4 Cell-Free Reactions  
 Cell-free transcription-translation systems (NEB, PURExpress) were prepared for freeze-
drying according to following recipe: cell-free solution A, 40%; cell-free solution B, 30%; RNase 
Inhibitor (Roche, 03335402001, distributed by MilliporeSigma), 2%; chlorophenol red-b-D-
galactopyranoside (Roche, 10884308001, distributed by MilliporeSigma, 24mg/ml), 2.5%; with the 
remaining volume reserved for LIRA-based ribocomputing switch DNA, water and lacZα peptide 
added to a final concentration of 2 µM. When testing ribocomputing devices with paper-based 
system, the final concentrations of the plasmids are 15ng/µl.  
 Filter paper (Whatman, 1442-042) for deposit and freeze-drying the cell-free system was 
first blocked with 5% bovine serum albumin (BSA) overnight. The paper was washed three times 
in water for 5 to 10 min after overnight blocking. The paper was transferred on a hot plate at 50˚C 
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for drying and then cut into 2mm diameter paper disks with a biopsy punch. The disks were then 
transferred into 200µl PCR strips and 1.8µl of the above cell-free reaction mix was applied to 
each of them. Liquid nitrogen was used for freeze the PCR strips containing those paper devices. 
The frozen paper disks were dried overnight with a lyophilizer. Plate reader tests were carried out 
on the freeze-dried paper disks 2-4 days later. With the systems stored in nitrogen environment, 
shielded from light and together with the silica gel desiccation packages as described previously, 
the paper disks remained active for at least a month under room temperature. 
 
4.2.5 NASBA 
 NASBA experiments were carried out following the standard protocols: reaction buffer 
(Life Sciences, NECB-24; 33.5%), nucleotide mix (Life Sciences NECN-24; 16.5%), RNase 
inhibitor (Roche, 03335402001; 0.5%), 12.5 µM of each DNA primer (2%), nuclease free water 
(2.5%) and RNA amplicon (20%) were assembled at 4˚C. After being incubated at 65˚C for 2 min 
and a 10 min incubation at 41˚C, 1.25µl enzyme Mix (Life Sciences NEC-1-24; 25%) was added 
to the reaction. The reaction took place at 41˚C for 2 h and was then diluted 1:6 into water before 
applying to the freeze-dried paper devices. 
 
4.3 Results and discussion 
4.3.1 LIRA-based ‘Or’ logic gates 
 A 2-input ‘Or’ logic nanodevice comprises two different LIRAs, and the RBS and start 
codon are localized in the shared bottom stem, so each RNA input can disrupt the bottom stem to 
turn on gene expression (Fig. 4.1A). A hairpin reconfiguration domain was inserted between 
those two LIRA hairpins to maintain a stable ‘ON’ state when the upstream hairpin is disrupted. 
And strong GFP expressions at similar levels were detected for all logical TRUE conditions tested 
via flow cytometer (Fig. 4.1B). 
 A 3-input ‘Or’ logic gate nanodevice is constructed in the same way with two hairpin 
reconfiguration domains inserted to each of the upstream hairpins (Fig. 4.1C). Each single input 
can disrupt its corresponding hairpin under the help of the small hairpin reconfiguration domain to 
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release the blocked RBS and start codon from the bottom stem. The output signals were detected 
for all logical TRUE conditions, but the signals detected from single-input cases are weaker than 
those with 2 to 3 inputs (Fig. 4.1D). This may be resulted from the non-fully disruption of the 
structure, as the entire tightly sealed structure is too stable for single RNA input to completely 
disrupt. When two or more RNA inputs work together, the entire structure can be totally unwound. 
 
4.3.2 LIRA-based ‘And’ logic gates 
 To design nanodevice with 2-input ‘And’ logic computation function, besides fusing two 
different LIRAs together, the RBS and start codon are also arranged into the last LIRA hairpin 
structure (Fig. 4.2A). In this case, the disruption of upstream LIRA by the RNA input cannot 
release the RBS and start codon. But without the disruption of the upstream LIRA, the RNA input 
for the last LIRA cannot disrupt the entire tightly sealed nanostructure. Only when the two RNA 
inputs are transcribed together, the expression of reporter protein can be turned on. As 
demonstrated by the flow cytometry measurement, strong GFP expression was detected with the 
logical TRUE condition, and no signal outputs were detected for all logical FALSE conditions (Fig. 
4.2B). This 2-input ‘And’ logic design does not require a hairpin reconfiguration domain. We also 
tested a 2-input ‘And’ logic nanodevice with a hairpin reconfiguration domain inserted, but it 
shows lower ON/OFF level compared with this one. 
 A 3-input ‘And’ logic nanodevice is also constructed and inserted with two independent 
hairpin reconfiguration domains (Fig. 4.2C). Each RNA input alone or any pair of two RNA inputs 
cannot disrupt the final LIRA to release the blocked RBS and start codon. When all three RNA 
inputs work together to disrupt each hairpin sequentially, strong GFP signal output can be 
detected. And from the flow cytometry measurement, we can see that the correct truth table was 
successfully achieved (Fig. 4.2D). 
 
4.3.3 LIRA- and toehold-switch-based ‘And’ logic gates 
 Although LIRA-based ribocomputing devices solved the limitations of toehold-switch-
based ones, the design difficulty for LIRA-based devices is much harder than toehold switch ones. 
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LIRA-based logic gates usually requires more complex secondary structures with the increasing 
numbers of inputs, which will result in stringent sequence requirements during designing. Since it 
is very useful to get a design strategy that can combine the advantages from both toehold switch 
and LIRA design strategies, we further validated a new type of ‘And’ logic gates, which we named 
LIRA-Toehold ‘And’ logic gates. 
 We first validated a 2-input ‘And’ logic gate device (Fig. 4.3A). In this design, no hairpin 
reconfiguration domain is required, and toehold domain from toehold switch is blocked in the 
stem of LIRA, just at the position where RBS was located previously. Trigger for LIRA can disrupt 
the hairpin structure to release the toehold domain accessible for toehold trigger binding. 
However, toehold trigger itself cannot unwind the entire structure, since the toehold domain is 
tightly sealed in the LIRA stem, which is demonstrated by flow cytometry measurement (Fig. 
4.3B). 
 Then we constructed a 3-input ‘And’ logic device (Fig. 4.3C). In this design, the 5’ toehold 
switch has a completely changed shape compared with normal toehold switches. Its loop domain 
is completely removed, and only leaves the binding domain together with toehold domain. Its 
stem is just a single-stranded DNA, which partially base-paired with part of repressed gene 
sequences. Testing with flow cytometry, we got a correct truth table (Fig. 4.3D). 
 
4.3.4 Paper-based diagnostic with logic gates 
 For previously developed paper-based diagnostic platforms, each paper device can only 
detect one type of virus, which hinders its application in detecting multiple viruses or different 
virus subtypes. Moreover, each sensor only targets a small region in the virus genome, which 
may not be reliable for diagnostics that require stringent accuracies. We thus investigated 
whether the logical computation ability of LIRA-based ribocomputing nanodevices can be 
incorporated into diagnostic applications. In principle, ‘Or’ logic nanodevice should be able to 
carry out the detection of multiple viruses or different subtypes of one virus on the same paper 
device, and ‘And’ logic nanodevice should provide more accurate readouts by targeting at 
multiple domains in the virus genomes. 
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 To demonstrate this, different subtypes of HIV1 were selected for ribocomputing 
nanodevice designs, since HIV is regarded as one of the major worldwide health concerns and 
HIV1 is the predominant virus among all HIV infections worldwide154. There are four groups 
belong to HIV1, group M, N, O and P, and group M is the major one that responsible for the 
global HIV epidemic155. Under group M, there are 9 different subtypes, subtypes A, B, C, D, F, G, 
H, J and K. We chose subtypes A, B and C for logic ribocomputing studies, since they account for 
over 70% infections of HIV1 worldwide155.  
 We downloaded and aligned 114 sequences for subtype A, 81 sequences for subtype B 
and 200 sequences for subtype C from NCBI database and got conserved sequences for each 
subtype, respectively. We also found a region that conserved in all those 3 subtypes. Based on 
the conserved sequences, we designed a 2-input ‘Or’ logic nanodevice targeting at HIV1 
subtypes B and C (Fig. 4.4A) and a 2-input ‘And’ logic nanodevice targeting at the conserved 
domain in subtype B and the conserved domain found in all three subtypes (Fig. 4.4C). 
 Unlike the in vivo nanodevices, we made some modifications to the nanodevice 
structures. With respect to ‘Or’ logic nanodevice, we set the binding region covers the full loop 
and stem (Fig. 4.4A). For ‘And’ logic nanodevice, we inserted a hairpin reconfiguration domain to 
the structure and designed a smaller loop for the downstream hairpin (Fig. 4.4C). RNA-keys are 
amplified by NASBA with synthetic RNA as templates, and applied to paper devices freeze-dried 
with either ‘Or’ or ‘And’ ribocomputing nanodevices. For 2-input ‘Or’ logic gate, NASBA products 
from subtype B or subtype C can turn on the system efficiently demonstrated by the color change 
(Fig. 4.4B). For 2-input ‘And’ logic gate, color change can only occur when both NASBA products 
from subtype B are being applied on to the paper device (Fig. 4.4D). 
 To better illustrate our paper-based diagnostic platform with logic computing functions, 
we further developed sensors targeting at hemagglutinin (HA) and neuraminidase (NA) genes of 
different influenza A subtypes. The influenza A subtypes that contain same HA or NA genes show 
high similarity in RNA sequences, but show completely different sequences with irrelevant HA or 
NA genes (Fig. 4.5A). Since conventional single input riboregulator is not able to distinguish one 
from another, the two-input ‘and’ logic strategy can be incorporated by targeting at both HA and 
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NA genes at the same time when implement influenza A viruses genotyping. We developed 3 
sensors targeting at H5N1, H1N1 and H1N2 subtypes, and tested them with either single cognate 
RNA input or both cognate RNA inputs. Only when both cognate RNAs were added to the paper 
device, can we detect color change reaction (Fig. 4.5B). Both RNA inputs from different subtypes 
was not able to induce the paper-based reaction. Thus, with 2-input ‘and’ logic devices, we can 
realize more accurate diagnostic or even in subtypes genotyping applications. 
 
4.4 Conclusion 
 The functional ‘Or’ and ‘And’ logic ribocomputing nanodevices provide excellent in vivo 
performance with low leakage at ‘OFF’ states from logical FALSE conditions and high ‘ON’ state 
signals with logical TRUE conditions. During NUPACK design and experimental screening, we 
found that the prescribed structure in the design script is more important for getting functional 
devices, especially for the designs of ribocomputing devices. With improper parameters set for 
prescribed structures, such as stem and loop lengths, NUPACK package can generate designs 
that will probably fail in experimental tests. If the prescribed structure is suitable, working devices 
can always be screened from multiple designs.   
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Figures 
 
Figure 4.1 Structure and in vivo validation of LIRA-based ‘or’ logic. 
(A) Design of 2-input ‘Or’ logic gate and schematic of interaction with triggers; (B) In vivo 
performance of 2-input ‘Or’ logic gate, ON/OFF ratios (left) and logic scale on state signal (right); 
(C) Design of 3-input ‘Or’ logic gate; (D) In vivo performance of 3-input ‘Or’ logic gate, ON/OFF 
ratios (left) and logic scale on state signal (right). 
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Figure 4.2 Structure and in vivo validation of LIRA-based ‘and’ logic. 
(A) Design of 2-input ‘And’ logic gate and schematic of interaction with triggers; (B) In vivo 
performance of 2-input ‘And’ logic gate, ON/OFF ratios (left) and logic scale on state signal (right); 
(C) Design of 3-input ‘And’ logic gate; (D) In vivo performance of 3-input ‘And’ logic gate, ON/OFF 
ratios (left) and logic scale on state signal (right). 
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Figure 4.3 Structure and in vivo validation of LIRA- and toehold-switch-based ‘and’ logic. 
(A) Design of 2-input ‘And’ logic gate and schematic of interaction with triggers; (B) In vivo 
performance of 2-input ‘And’ logic gate, ON/OFF ratios (left) and logic scale on state signal (right); 
(C) Design of 3-input ‘And’ logic gate; (D) In vivo performance of 3-input ‘And’ logic gate, ON/OFF 
ratios (left) and logic scale on state signal (right). 
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Figure 4.4 Logic gates tests with paper-based diagnostic platform. 
(A) Design of 2-input ‘Or’ logic gate for HIV1-B and HIV1-C detection; (B) Detection of HIV1-B 
and HIV1-C, photos were taken after 1.5 hours; (C) Design of 2-input ‘And’ logic gate for HIV1-B 
differentiation; (D) Differentiation of HIV1-B from HIV1-A and HIV1-C, photos were taken after 2.5 
hours.  
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Figure 4.5 Influenza A subtypes genotyping with paper-based diagnostic platform. 
(A) Targeting sequences of different influenza A subtypes, the mismatched bases are highlighted 
with red color. (B) Paper-based detection of different influenza A subtypes. 
  
H1N2
H1N1
H5N1
Hemagglutinin(HA) Neuraminidase(NA)
......CCATGCCAACAACTCAACCGACACTGT......
......TCATGCGAACAATTCAACAGACACTGT...... ......CGAAGAGAACACAATCTGGACTAGCGGGAGC......
......CAAAGAGAGCACAATTTGGACTAGTGGGAGC......
H5N2
H5N1
H1N1
......AAGGTGACCAAATCTGCATTGGTTACCAT......
......AAAGCGATCATATTTGCATTGGTTATCAT...... ......ACAATTTGGACTAGTGGGAGCAGCATATCTTT......
......ACAATCTGGACTAGCGGGAGCAGCATATCCTT......
H1N1
H1N2
H3N2
......ACATTTACAACCGCAAATGCAGACACATT......
......ACATTTACAGCTGCATATGCGGACACAAT...... ......ACTTCAGGTACATATGGAACAGGCTCATGGC......
......ACCTCAGGTACATATGGAACAGGCTCATGGC......
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
Δ
O
D
57
5
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
Control H5 N1 H5N1 H1N1 H5N2
Δ
O
D
57
5
Δ
O
D
57
5
Control H1 N1 H1N1 H1N2 H5N1 Control H1 N2 H1N2 H1N1 H3N2
A
B
	 75	
CHAPTER 5 
CONCLUSION AND FUTURE DIRECTIONS 
The fundamental building blocks for constructing complex synthetic gene networks are 
effective biological parts with wide dynamic range and low crosstalk. However, the limited number 
of orthogonal parts still hinders the construction of effective biological networks. RNA-based 
components are promising solutions to solve this problem, since their predictable base pairing 
rules, which also provides RNA-based parts with higher programmability than protein-based parts. 
The toehold switch is a breakthrough in RNA-based component designs. By blocking both RBS 
and start codon in a hairpin structure but without binding to these sequences, gene expression 
can be regulated by a short trigger RNA molecule that can adopt nearly any sequence. By 
rationally modifying the design parameters of toehold switch, such as loop size and toehold 
length, the ON/OFF ratios of toehold switches can be tuned accordingly, with the ON/OFF ratio of 
the best toehold switch reaches over 600-fold. Besides its high dynamic range, the toehold switch 
also provides extremely low crosstalk between different designs. Moreover, toehold switch based 
complex ribocomputing devices also perform well in vivo, which demonstrated the high 
programmability of RNA-based components. Since no sequence constraints exist in trigger RNAs, 
the toehold switch is developed to detect RNA molecules with completely arbitrary sequences. 
Viruses with RNA genomes, like Ebola and Zika, were all successfully detected by incorporating 
with paper-based diagnostic platform. To detect clinical samples, in which virus concentration is 
very low, isothermal amplification reaction, such as NASBA, is incorporated. With target RNA 
amplification by NASBA, paper-based diagnostic platform successfully detected Zika virus in 
clinical samples.  
 With this platform, we turned to see whether we could expand the paper-based platform 
to detect other viruses. Norovirus can cause human gastroenteritis and lead to over 200,000 
deaths in developing countries annually, so a portable and low-cost detecting method is required 
urgently by people living in rural areas. Compared with traditional detection methods, the paper-
based diagnostic platform exhibits several advantages. First, it does not require any expensive 
instrument, such as thermal cycler and plate reader, to either carry out the reaction or detect the 
	 76	
reaction readout. Second, it is portable and low-cost, since all components are freeze-dried onto 
a small paper disk, and reactions can be activated by simply rehydration with RNA target. Third, 
only specifically amplified RNA targets can turn on the color change reaction, since the amplified 
RNA targets need to interact with the sensor, whose sequence is pre-defined. This mechanism 
completely prohibits false positive readouts. However, unlike antibody-based detection, paper-
based diagnostic platform usually requires longer times, which includes 2-hr isothermal 
amplification and over 1-hr paper-based reaction. To shorten the time cost, we can either shorten 
the reaction time for isothermal amplification or decrease the time cost for paper-based reaction. 
But a 2-hr isothermal amplification is required for amplifying samples containing extremely low 
virus concentrations. Although virus concentrations can reach up to femtomolar range in some 
clinical samples, most of them only contain viruses in picomolar or attomolar ranges, which 
requires 2 hr of isothermal amplification to produce enough RNA targets for paper-based 
reactions. 
To speed up the process, we began to improve the paper-based color change reactions 
to see whether we could find a proper way to shorten the time cost. Since lacZ is a relatively long 
reporter protein compared with GFP and mCherry, the time cost should be decreased if we can 
replace it with shorter ones. Thus, alpha-complementation of lacZ is incorporated into our designs. 
Each lacZ monomer contains two subunits, lacZɑ and lacZω, and lacZɑ is ~50 amino acids long 
while lacZω is ~970. Without lacZɑ, lacZω itself cannot form active tetramer. With this 
mechanism, we replaced lacZ gene with the short DNA oligonucleotides encoding for lacZɑ 
peptides, and freeze-dry the lacZω protein together with all the other components that required 
for paper-based diagnostic system. Since lacZɑ is much shorter than lacZ, the time requirement 
during transcription and translation is decreased. And the folding of lacZ protein is also 
accelerated, because the large subunit lacZω is pre-synthesized and being freeze-dried onto 
paper disks directly, and the folding of lacZω has been done during synthesis. With this 
improvement, we got 41% reduction for time cost during paper-based reactions. 
Although toehold switch provides excellent performance, it has its own limitations, such 
as noticeable signal leakage in vivo, unwanted amino acids being translated with reporter protein 
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and sequence constraints of in-frame stop codon. To overcome the above limitations, we 
developed a new type of de-novo-designed riboregulator, known as a LIRA, which also shows 
wide dynamic range and low cross talk for regulation of gene expression. We designed 24 
devices, and 33.3% of them showed ON/OFF ratio higher than 100, which is larger than the 
percentage observed for the first-generation toehold switches. Combined with our paper-based 
colorimetric diagnostic platform and cell-free system, LIRAs were engineered for detecting a 
variety of virus RNAs, such as HIV, Zika, DENV, Norovirus and YFV. Among those pathogen 
detections, the detection limit of DENV can reach down to 20aM, which equals to ~12 copies/µl 
sample.  
Toehold-switch-based ribocomputing devices also have their own limitations. For ‘Or’ 
logic devices, each input will induce the translation of downstream toehold switches into peptides 
together with reporter proteins. The secondary structure of downstream toehold switches affect 
the protein expression induced by upstream inputs. With respect to ‘And’ logic, inputs are not 
independent since all RNA triggers need to be assembled together to form the full-length trigger 
first, and then turn on gene expression by interacting with toehold switch. All above limitations 
hinder their applications in many aspects. To overcome those limitations, we developed LIRA-
based ribocomputing devices. For ‘Or’ logic, each input has exactly same output proteins, without 
adding any unrelated amino acid to output proteins. Protein expression level is at similar level 
with the same amount of RNA inputs. For ‘And’ logic, each input is completely independent, 
which makes it possible for detecting multiple RNA molecules with arbitrary sequences at the 
same time. Based on this, we also constructed LIRA-based ribocomputing devices into virus RNA 
sensors to expand the use of paper-based diagnostic platform. 
RNA-based biological parts exhibit many advantages over protein- and promoter-based 
biological parts, which usually take complex layered designs and cost substantial cell resources 
for carrying out their functions. RNA-only devices thus can be engineered for versatile 
applications in many aspects. For in vivo studies, more complex biological circuits can be 
constructed via either toehold or loop-mediated RNA-RNA interactions. Toehold switch and LIRA 
are all translational regulating designs, but they can be easily engineered into transcriptional level 
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controls by regulating the formation of transcriptional terminators during transcription. By 
constructing transcriptional level RNA regulators, in which RNA input can regulate the 
transcription of RNA output, RNA-only and layered circuits can be realized. Since RNA is more 
programmable than protein based circuits, complex biological circuits with multiple layers will 
become much easier with RNA based in silico designs. Another important point for LIRA is that 
there is completely no sequence constraint for LIRAs, so it is more compatible with RNA aptamer 
and endogenous mRNA and miRNA regulations than toehold switches. LIRA can thus be 
incorporated into either RNA imaging, gene regulation in mammalian cells or even in therapeutic 
studies. With respect to in vitro application, diagnostic may still be the major point. But those 
RNA-based designs can be engineered with different outputs instead of using color change 
output signals. This might be helpful to improve sensitivity of the RNA detecting system and 
decrease the time cost for detecting the readouts, which is the major drawback for the paper-
based diagnostic platform. 
In summary, RNA based biological parts are promising building blocks for constructing 
complex biological circuits with versatile functions. Considering its high programmability and 
degradable properties, RNA based designs can serve human with a promising ‘key’ to solve 
complicated ‘locks’ in the future. 
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